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Currently, the best way to reduce the mortality of cancer is to detect and treat it in 
the earliest stages. Technological advances in genomics and proteomics have opened a 
new realm of methods for early detection that show potential to overcome the drawbacks 
of current strategies. In particular, pattern analysis of mass spectra of blood samples has 
attracted attention as an approach to identification of potential biomarkers for early 
detection of cancer. Mass spectrometry provides rapid and precise measurements of the 
sizes and relative abundances of the proteins present in a complex biological/chemical 
mixture. However, this high-throughput nature of mass spectrometry has also raised a 
need for the development of efficient and effective bioinformatics tools for finding 
biologically meaningful information. Many scholars are interested in preprocessing of 
raw mass spectra and in extracting and selecting features from preprocessed mass spectra. 
These are key issues for accurate biomarker identification. Thus, in order to improve the 
process of biomarker identification using mass spectrometry, I have postulated a noise 
 ix 
model for MALDI TOF mass spectrometry from the perspective of stochastic signal 
processing, and have attempted to measure the spectral characteristics of components in 
the noise model. Noise in mass spectrometry can interfere with identification of the 
biochemical substances in a sample. I assumed that the noise in MALDI TOF mass 
spectrometry is composed of three components: noise from instrumentation, noise from 
random ion motions, and chemical noise. In this dissertation, I have separated and 
analyzed noise from instrumentation and chemical noise using parametric power spectral 
density estimation and wavelet-based analysis, respectively. In addition to these noise 
analysis studies, I also have designed an algorithm that can select independent and 
discriminant features from mass spectra of complex protein samples by reducing 
redundant and irrelevant information.  
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Chapter 1: INTRODUCTION 
1.1 STATEMENT OF THE PROBLEM 
Cancer is a major public health concern in the U.S. In 2006, there will be about 
1.4 million new cancer cases and more than 564,000 deaths due to cancer [1, 2]. Cancer 
accounts for one of every four deaths in the U.S. [1]. Currently, the best way of reducing 
the mortality of cancer is to detect and treat it in the earliest stages [3]. For example, 
when breast cancer is detected at the advanced stage, in which cancer is metastasized 
from the original organ to others, the survival rate is only 26%. However, when breast 
cancer is detected at the early stage, in which cancer is localized in organ of origin, the 
survival rate increases to 98% [1]. Similarly, the survival rate of prostate cancer soars 
from 34% when the cancer is detected at the advanced stage to nearly 100% at the early 
stage [1]. 
A cancer screening test is considered efficacious if it results in a decrease in 
cause-specific mortality. Necessary evidence in favor of a particular screening test 
includes earlier detection of disease than would have occurred due to presentation of 
symptoms and evidence that earlier treatment will result in a better outcome. (There is a 
helpful overview online at http://cancer.gov/cancertopics/pdq/screening/overview). 
Screening and diagnostic tests are typically evaluated in terms of their sensitivity and 
specificity. Sensitivity is the fraction of disease cases that are correctly identified as 
disease. Specificity is the fraction of non-disease cases that are correctly identified as 
non-disease. 
Currently, there exist effective screening tests for use in the general population for 
only a few types of cancer. The screening methods that are best supported by the 
evidence to date are (1) the Pap smear for cervical cancer screening, (2) mammography 
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for breast cancer detection, and (3) fecal occult blood testing for colorectal cancer 
screening. While there are limitations to each of these methods, there is evidence that 
they have made substantial contributions to reducing the morbidity and mortality due to 
cancer.   
A Pap smear is an exfoliative cytological staining procedure that can help identify 
premalignant and malignant changes in the cervical epithelium. The incidence of, and 
mortality of women due to, cervical cancer has declined about 70% in the U.S. since the 
Pap was introduced in the 1950s. Use of this screening test reduces the incidence as well 
as mortality since the Pap smear can detect precancerous changes that can be treated. 
However, with a specificity of only 63%, many false-positive Pap smears occur in 
screening the general population, in which cervical cancers and precancerous lesions are 
thankfully rare [4]. Unfortunately, false negative Pap smears also occur since the 
sensitivity of the exam is 73% [4]. 
Mammography, x-ray imaging of the breasts, is used to detect breast cancer. 
Mammography has reduced the mortality of breast cancer by approximately 25-30% in 
the U.S. since the 1970s [5, 6]. Mammography also suffers from false positives due to the 
combination of moderate specificity and low disease prevalence. Only 15-34% of the 
positive cases from mammography are found to be actually malignant at biopsy [7, 8]. 
False negatives also occur since the sensitivity of mammography is approximately 90% 
[9]. 
Fecal occult blood testing (FOBT) is used for the early detection of colorectal 
cancer. It can detect colorectal cancer by measuring blood loss in the stool, which mainly 
occurs due to colorectal neoplasms [10, 11]. FOBT is reported to have reduced the 
mortality of colorectal cancer in the U.S. by 33% [10-13]. FOBT has a fairly high 
specificity of 96-98% [13]. However, because the sensitivity of the FOBT is merely 40% 
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[13], there is concern that the diagnosis and treatment of colorectal cancer can be delayed 
due to false negative tests.  
An ideal cancer screening method would be accurate, non-invasive, and 
inexpensive. As discussed above, the accuracy levels of existing screening methods are 
far from ideal. The false negatives resulting from screening methods in current use delay 
the diagnosis of cancer, which can lead to increased morbidity and mortality. The false 
positives generated by the early detection methods used in current practice necessitate 
additional diagnostic testing which increases costs, discomfort, and stress. Existing 
screening modalities are all invasive to some extent: a Pap smear is obtained from a 
pelvic exam, mammography is based on exposure to ionizing radiation and compression 
of the breasts, and FOBT requires a stool sample. Many variables are believed to impact 
compliance with existing screening programs, but physical discomfort and 
embarrassment are probably important factors (e.g., [14]). The costs associated with 
current approaches to cancer screening remain problematic as well (e.g., [15]). 
Recent technological advances in genomics and proteomics have opened a new 
realm of early detection, showing potential to overcome the drawbacks of current early 
detection strategies. A biomarker is a biologically derived molecule in the body that 
indicates the progress or status of a disease. The concentration level or pattern of 
biomarkers related to a certain type of cancer can be used for early detection or diagnosis. 
Studies of the application of biomarkers for early cancer detection can be summarized 
into two categories: the usage of a single biomarker and the pattern analysis of multiple 
biomarkers. 
When a single biomarker is used, the concentration level of the biomarker is taken 
as an indicator of the presence or absence of cancer. A threshold is set on the 
concentration level of a biomarker and if the concentration level is higher than the 
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threshold, the specimen is considered “positive” for cancer. An example of early 
detection based on a single biomarker is the use of prostate-specific antigen (PSA) in 
blood to detect prostate cancer. PSA is a protein secreted by the epithelial cells of the 
prostate gland. The PSA level in blood is generally low in healthy people or patients with 
benign prostate disease such as benign prostatic hyperplasia (BPH), but it tends to rise in 
many patients with malignancies [16]. However, the specificity of using the 
concentration level of PSA as an indicator of prostate cancer ranges from only 18-50% 
with a sensitivity of 70-90% [16]. The low specificity causes many false positives to 
occur; therefore, unnecessary biopsies are performed to corroborate the absence of 
prostate cancer. There is considerable debate as to whether screening for prostate cancer 
by PSA is efficacious [3, 17-20]. 
The problems encountered with the PSA biomarker suggest limitations that may 
plague any test based on a single biomarker. Given the high level of biological variability 
and the fact that cancer cells are derived from normal cells in the body, it may not be 
possible to identify a single circulating protein that can identify the presence of cancer 
with high sensitivity and specificity in the general population. Even for high-risk 
populations (e.g., CA 125 for women at high risk for ovarian cancer [21]), it is unlikely 
that single biomarkers will provide as accurate testing as the use of multiple biomarkers.  
An important difficulty in developing tests based on single biomarkers is that the 
identification process demands a vast amount of time and labor [19]. Traditionally, 2-D 
gel electrophoresis (2DE) has been used for biomarker identification in tandem with mass 
spectrometry [17, 19, 22-24]. A protein expressed differently between cancer and normal 
specimens is extracted using 2DE and the extracted protein is identified by peptide 
fingerprinting using mass spectrometry and protein/peptide databases. 2DE is the 
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bottleneck of this process because it is extremely time-consuming and laborious [19, 25, 
26]. 
Recently, pattern analysis of multiple biomarkers in blood samples has attracted 
attention as an alternative to the usage of a single biomarker for early detection of cancer. 
The pattern differences of protein profiles between cancer and healthy samples are 
perceived using data mining algorithms. Multiple proteins rather than a single protein are 
used as a ‘panel’ of biomarkers in this approach. Because these pattern differences 
originate from the complexity of blood, which is a mixture of thousands of proteins, a 
protein profiling modality with high-throughput and high sensitivity is required.  
Mass spectrometry has the potential to meet these requirements by providing the 
sizes and relative abundances of the proteins in a complex biological/chemical mixture in 
a rapid and precise manner [27-31]. Recently, studies have been performed on a several 
types of cancer, including ovarian [32-46], prostate [41, 47-57], breast [58-60], bladder 
[61, 62], lung [63-78], liver [79], pancreatic [80-85], renal cell carcinoma [86], colorectal 
[87], leukemia[88], and astroglial tumor [89]. Most of these studies reported fairly high 
sensitivities and specificities (over 80%). However, many questions have been raised 
about the reliability of these reported results due to the “black box” methods employed 
[52, 90-94]. 
Diamandis pointed out that the peak height does not linearly correspond to the 
protein abundance because mass spectrometry only provides the relative abundance of 
proteins in a sample [92]. He also inquired about why different data mining algorithms 
had produced different sets of potential biomarkers. He took as an example the studies on 
prostate cancer performed by Qu et al. [53] and Petricoin et al. [95]. They achieved high 
sensitivities (96%: Qu et al., 95%:Petricoin et al.) and specificities (98%: Qu et al., 
83%:Petricoin et al.) with different sets of potential biomarkers selected through different 
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data mining algorithms. Another question is why known biomarkers, for example PSA, 
do not seem to be reflected by the studies so far and the potential biomarkers found in 
these studies have fairly low mass [90-92]. Since low mass proteins are easily cleared by 
the kidney, the efficacy of a panel of low mass proteins appears to be suspicious. Related 
to this, Diamandis and Merwe also raised another question on whether or not the putative 
biomarkers identified through the “black box” methods originate from cancer-specific 
pathological states in the body [94]. They took an example Koomen et al.’s study on the 
identification of potential biomarkers for pancreatic cancer [84]. Koomen et al. identified 
several biomarker candidates for pancreatic cancer from mass spectra of human plasma 
of healthy people and pancreatic cancer patients using statistical and biochemical tests 
[84]. However, Diamandis and Merwe argued that these biomarker candidates can be 
only high abundance non-cancer-specific proteins in blood, which are produced by 
nonspecific epiphenomena of cancer presence. Moreover, they suspected that mass 
spectrometry technologies such as MALDI TOF or SELDI TOF are not sensitive enough 
to detect low abundance clinically useful biomolecules without an aid of powerful 
fractionation [94].  
In addition to Diamandis’ questions, Baggerly et al. [93, 96] emphasized the 
problems in quality control indicated by the lack of reproducibility of the studies of 
Petricoin et al. [95] and Zhu et al. [35]. In these both studies, the ovarian cancer data sets 
posted on the website of the clinical proteomics program under the National Cancer 
Institute (http://home.ccr.cancer.gov/ncifdaproteomics/) were analyzed to identify 
diagnostic signatures for ovarian cancer. Baggerly et al. attempted to reproduce the 
experimental results obtained by Petricoin et al. by following the proposed bioinformatic 
algorithms as much as possible; however, Baggerly et al.’s analyses imply that the 
apparent successes of the study may have been due to artifacts of sample processing 
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rather than actual biological pattern differences [93]. In the analyses on Zhu et al.’s 
study, Baggerly et al. also showed that the peaks identified as potential biomarkers in one 
data set may not have consistently occurred in another set measured on a different date 
from the first set [96]. Similarly, Yasui discussed the variability of the relative abundance 
of the same protein across chips and samples, which also points to the need for active and 
systematic internal quality controls [52]. 
Recently, some progress has been made in addressing these important questions. 
For example, low mass biomarkers may be more meaningful than many had believed 
because other high abundance and high mass proteins such as albumin can act as carriers 
of low mass biomarkers. These carrier proteins enable low mass biomarkers to stay in the 
body longer than expected [97]. Powerful fractionation techniques amplify the 
concentration of these low mass biomarkers by isolating them from the carrier proteins 
such that mass spectrometers can sufficiently detect the pathological signatures of these 
low mass biomarkers [18, 97].  
In addition, in response to Baggerly et al. [96], Liotta et al. pointed out that the 
two ovarian data sets used in Zhu et al.’s study were measured under different 
experimental settings (e.g., chemistries on protein chips, pH, laser energy intensity, etc.) 
as well as on different days; thus, simple comparisons of two different mass spectra data 
sets may lead to a hasty generalization about the reproducibility of the technique [98]. 
Similarly, Grizzle and Meleth also maintained that it would be very unlikely for different 
laboratories to derive similar sets of biomarker candidates when applying different 
bioinformatics algorithms to samples obtained from non-identical patient populations 
[99].  
Such issues related to reproducibility can be resolved to some extent if strongly 
standardized calibration and instrumentation protocols are shared among laboratories. 
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Recently, Semmes et al. reported that “between-laboratory” reproducibility of SELDI 
TOF MS can reach “within-laboratory” reproducibility levels if calibration and 
instrumentation protocols are strongly standardized among different laboratories [100]. 
Six different institutions succeeded in classifying prostate cancer sampled from healthy 
samples using a classifier trained in an institution within an acceptable variance of error 
rates after calibrating the SELDI TOF MS machines with a standard of pooled serum 
samples. This study was performed as part of an on-going effort to validate the approach 
of cancer detection through serum protein expression profiling using SELDI TOF MS 
[101]. 
However, many questions remain unanswered. In Semmes et al.’s study, while 
mass accuracy of the healthy samples used for the quality control agreed within an 
acceptable variance, their peak intensities, especially small peak intensities, showed fairly 
high variation despite of careful calibration. Moreover, for classification, Semmes et al. 
selected prostate cancer and healthy samples that had been used in building the classifier 
in their previous study and on which the classifier performed well. Thus, as Semmes et 
al. discuss in their article, their study only shows the possibility that the experimental 
platform can be reproducible under very rigorous unified calibration and instrumentation 
protocols and more work is needed on this important issue.  
For reliable early detection based on pattern analysis of multiple biomarkers, 
more rigorous and systemic approaches are needed. Since most such pattern differences 
in mass spectra of samples such as plasma/serum are very subtle, noise can cause false 
positives or false negatives in peak detection by distorting the true shape of the mass 
spectrum. Thus, effective noise reduction that can maximally reveal the true chemical 
information of mass spectra must be developed to identify truly powerful biomarkers. In 
addition, selecting the smallest set of discriminant features that can inform the 
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pathological status of samples must also follow. In this dissertation, as a step toward 
effective noise reduction, I propose a noise model for MALDI TOF mass spectrometry, 
and analyze the stochastic natures of some of the noise components of the model. In order 
to handle a great number of features from MALDI TOF mass spectrometry successfully, I 
also develop a feature selection algorithm that can consider the interrelationships between 
features as well as the discrimination abilities. 
 
1.2 OVERVIEW OF THE DISSERTATION 
The dissertation is composed of a total of six chapters. Chapter 1 and 2 are 
extended from my review paper of a machine learning perspective on biomarker 
identification using mass spectrometry [102]. Relative to my review paper, these chapters 
have been updated with the most recent information of the research area. In Chapter 2, I 
briefly introduce the basic principles of MALDI TOF mass spectrometry, and the use of 
blood samples for early cancer detection. Then, I review the literature on the 
development of clinical decision support systems using mass spectrometry in an 
organized framework from a machine learning perspective. Study design and quality 
control (e.g., sample preparation and mass spectrometer parameter settings) are also 
extremely important issues because data quality, which is mostly determined by these 
processes, affects the overall performance of decision support systems. However, since 
these issues are beyond the scope of my research, I will refer the reader to other papers 
that have discussed the topic of study design and quality control for experiments based on 
protein profiling techniques [100, 103-106].  
In Chapter 3, I propose a noise model for MALDI TOF mass spectrometry and 
characterize the noise from instrumentation, which is one of the components of the 
proposed noise model. A parametric power spectral density estimation was used to 
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develop a stochastic signal model for noise from instrumentation. This method was 
designed by de Waele and Broersen to obtain a more reliable and robust model from 
multiple signal segments of a stationary random process [107]. To study the effects from 
the instrumentation environment and model type, mass spectra were measured from two 
MALDI TOF instruments of an identical model, but located at two different places, and 
from a more advanced model. The power spectral density (PSD) plots of the models of 
noise from instrumentation from the three machines were compared. In order to evaluate 
the effect of noise from instrumentation on a mass spectrum, I performed a simulation of 
MALDI TOF mass spectrometry, assuming that 57 human plasma proteins are analyzed 
by MALDI TOF. 
Chapter 4 describes my analysis of chemical noise, which is caused by chemical 
impurities like matrix material in the sample in MALDI TOF mass spectrometry. I 
characterized chemical noise using multiple realizations and developed algorithms based 
on the wavelet transform that can reduce the monotonically decreasing baseline and high 
frequency noise that result from chemical noise [108].  
In Chapter 5, I introduce a feature selection algorithm that was designed to select 
more independent and powerful features among a great number of features produced by 
protein profiling such as MALDI TOF mass spectrometry. This algorithm narrows down 
the search space for meaningful features by clustering features based on their linear 
relationship (i.e., correlation), and selecting a powerful representative from each feature 
cluster. I tested the efficacy of this algorithm using controlled simulation data and real 
protein profiles of breast cancer [109, 110], which were used in Pusztai’s breast cancer 
chemotherapy study [111].  
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In Chapter 6, I summarize my findings and suggest several study areas for more 
effective biomarker identification using MALDI TOF or other types of mass 
spectrometry from a biomedical informatics perspective.  
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Chapter 2: BACKGROUND 
2.1 MASS SPECTROMETRY 
Mass spectrometry provides rapid and precise measurements of the sizes and 
relative abundances of the proteins present in a complex biological/chemical mixture. 
Here I provide a very brief overview of the technique as it is typically used for 
identifying cancer biomarkers from blood samples. I refer the reader to other articles for a 
thorough review of mass spectrometry methods [112-117].  
The capabilities of a mass spectrometer are determined by its ion source, mass 
analyzer, and detector. Protein profiling of plasma and serum has been performed 
primarily with a matrix-assisted laser desorption ionization (MALDI) ion source or its 
derivative, the surface-enhanced laser desorption ionization (SELDI) ion source coupled 
to a time-of-flight (TOF) mass analyzer with a chevron microchannel plate detector. The 
only difference between SELDI and MALDI is the use of derivatized surfaces to capture 
peptides and proteins based on particular physical or biochemical characteristics prior to 
MALDI sample preparation and mass analysis. A brief description of MALDI TOF mass 
analysis is given in the following paragraphs. 
To prepare proteins or peptides for MALDI mass analysis, aqueous solutions of 
the proteins or peptides are mixed with solutions of matrix molecules, like sinapinic acid 
and 
! 
" -cyano-4-hydroxycinnamic acid, which are present in large molar excess 
compared to the proteins and peptides (10,000:1). Aliquots of this mixture are deposited 
on the MALDI plate and allowed to dry (this procedure is referred to as the dried droplet 
technique). The peptides and proteins selectively cocrystallize with the MALDI matrix as 
the solvent evaporates. After drying, the sample plate is introduced into the vacuum 
chamber of the mass spectrometer and placed in the MALDI ion source. To produce ions, 
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an ultraviolet laser (337 nm or 355 nm) is used to irradiate the matrix crystals. The 
energy from these photons is transferred into translational and vibrational energy causing 
desorption of matrix material containing the peptide and protein analytes. The softer 
process ionization of MALDI (when compared to laser desorption ionization) prevents 
fragmentation of the protein and peptide analytes [114]. However, ionized clusters of 
matrix molecules produce chemical noise, which interferes with the ion signals of interest 
that correspond to the peptides and proteins [118, 119]. 
After a delay of a few hundred nanoseconds (Wiley-McLaren time lag focusing), 
all ions are extracted from the source and accelerated into the TOF mass analyzer. The 
voltage settings in the ion source determine the range of optimized ion signal, i.e., the 
TOF has mass-dependent focusing. The ions drift in a field free region, where they are 
separated based on their mass-to-charge ratios. The principle behind this separation is 
that the potential energy of each ion in an electric field (
! 
U = zV ) is converted into the 






2 ). By setting these equations equal to one 
another, the TOF equation can be derived and rearranged to calculate the 
! 
m z  value for 
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In Eq. 2.1, z denotes the ion’s amount of charge, V the electric potential that 
accelerates the ion, m the ion’s mass, and v the ion’s velocity. In Eq. 2.2, l is the length of 
the flight tube of the TOF mass spectrometer and t the flight time of the ion. Eq. 2.3 
shows that the mass to charge ratio can be represented as a quadratic function of the flight 
time. Ions of the same 
! 
m z  have the same flight time and thus impact the detector at the 
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same time. When the ion strikes the detector, a cascade of secondary electrons is 
released. This current is captured by an anode and converted to a voltage using a 
preamplifier. The resulting voltage is recorded by a digital storage oscilloscope or by a 
digitizer card in a computer, and the amplitude of the signal corresponds to the number of 
ions that struck the detector in each bin of ion flight time. Other sources of noise from 
physical and electrical components of the mass spectrometer are also recorded (e.g., high 
frequency noise). 
Data are recorded as plots of intensity versus flight time and displayed as intensity 
versus 
! 
m z , which is referred to as a mass spectrum (Figure 1). In each mass spectrum, 
the individual ion signals correspond to nonvolatile analytes in the original sample. In 
protein profiling, these ion signals primarily correspond to peptides and proteins because 
of the analyte specificity of the matrices described above. The mass-to-charge ratios 
(
! 
m z ), displayed as the x-axis, can be used to calculate the molecular weights of protein 
or peptide in the profile. For the analysis of complex mixtures, like plasma or serum 
protein fractions, MALDI TOF MS has detection sensitivity in the 0.1 to 10 picomole 
range and mass measurement accuracy ranging from 0.01 to 0.5%. Ion signals in different 
mass spectra with centroids 
! 
m z  values within the mass measurement error tolerance 
should be considered to be the same peak (protein). Because of the complexity of the 
samples, which produces suppression effects, and the lack of internal and external 
standards for quantification, the intensity of the ion signals in a protein profile does not 
directly correlated to protein concentration [97]. Nonetheless, relative abundances of a 
particular ion signal can be determined by comparing mass spectra acquired from 
different samples. Thus, noise reduction and normalization schemes are critical to enable 
accurate statistical analysis of mass spectra. 
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Figure 2.1: Example of a mass spectrum in which the relative abundance is plotted as a 
function of the mass-to-charge ratio (
! 
m z ). Notice the monotonically decreasing 
baseline. A portion of the spectrum has been enlarged so that the high frequency noise is 
apparent. 
 
Ciphergen® (Freemont, CA) developed a SELDI TOF system to accomplish both 
fractionation and mass analysis in a succinct and accurate manner. SELDI TOF is a 
special case of MALDI TOF in which chromatography is performed using protein chips 
that can capture only those proteins that biochemically/chemically match certain binding 
characteristics (e.g., hydrophobic), even when a variety of proteins are mixed together in 
high concentrations [29, 120-124]. The selected “fraction” of proteins deposited on the 
protein chip is analyzed through MALDI TOF mass spectrometry. SELDI TOF enables 
the amplification of the mass abundance information of more proteins than other types of 
mass spectrometry by using a protein chip with a predefined chromatographic surface 
[97].  
Recently, more advanced types of mass spectrometry have been tested to improve 
the sensitivity to diagnostic patterns in protein profiling [34, 43, 55, 56]. Whereas 
traditional mass spectrometers provide 15,000-40,000 
! 
m z  data records, high-resolution 
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mass spectrometers can extend these to 350,000-400,000 
! 
m z  [34]. A hybrid 
quadrupole time-of-flight (QqTOF) such as the QSTAR pulsar I (Applied Biosystems, 
Inc., Framingham, MA, USA) is a frequently used model for this purpose. To the best of 
my knowledge, there have been no studies in which different types of high-resolution 
mass spectrometers are extensively compared and discussed. One expects that the 
development of more efficient and effective preprocessing and feature 
extraction/selection algorithms will be even more important issues for high-resolution 
MS than for traditional MALDI TOF or SELDI TOF because of the increase in size of 
each of data record. 
 
2.2 BLOOD SAMPLES 
This section reviews approaches that are being explored for cancer diagnosis 
using mass spectrometry of blood samples. There are several advantages to using blood 
samples because blood is readily accessible. While more invasive than some diagnostic 
imaging modalities, there is relatively little discomfort and low risk of side effects or 
adverse events associated with blood testing. Obtaining blood samples is less expensive 
than many other procedures. The primary disadvantage of using blood samples is that one 
expects that tumors located in most organs of the body will produce few proteins that will 
circulate in the blood at an appreciable level. 
Throughout my discussion, I refer generically to “blood samples”; however, the 
reader should note that mass spectrometry is not performed on whole blood but on 
derived products, particularly plasma or serum. Plasma is the liquid portion of blood in 
which the cells are suspended; serum is the fluid that remains after clotting proteins are 
removed from plasma [125]. The advantage of using plasma rather than serum is that it 
contains more proteins and that the protease activity, which leads to protein degradation, 
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is inhibited in plasma but not in serum. However, the disadvantage of using plasma is that 
low abundance proteins associated with disease may be difficult to detect in the presence 
of a large amounts of common proteins involved in clotting. Both plasma and serum have 
been used in studies of cancer diagnosis using mass spectrometry and it is not yet known 
which is best for this kind of analysis. 
There have been many studies of the serum/plasma proteomes using techniques 
such as 2D gel electrophoresis (e.g., [126]). However, to the best of my knowledge, this 
information has not been incorporated into studies of cancer diagnosis using mass 
spectrometry. It is possible that more accurate models for sample classification could be 
developed if prior knowledge of blood proteins could be properly taken into account. 
 
2.3 FRAMEWORK FOR SYSTEM DEVELOPMENT 
I employ a machine learning framework to review the literature on the 
development of clinical decision support systems utilizing mass spectrometry of blood 
samples. There are five stages of data analysis in this framework. First, the spectra are 
preprocessed to reduce the contribution of noise and to normalize the spectra from 
different samples such that they are comparable. Second, features reflecting the 
pathological status of a sample are extracted from the mass spectra. Interpretable features, 
such as peaks corresponding to distinct protein species, are generally preferred. Third, 
highly discriminant features are selected to reduce the dimensionality of the data, which 
increases the likelihood of successful classification. Fourth, machine learning models are 
designed to distinguish cancer from normal samples based on the selected features. Fifth, 
the system is evaluated in terms of clinically relevant metrics such as sensitivity and 
specificity. Ideally, separate data sets should be used for each stage. However, in practice 
some form of data partitioning of a single data set, such as cross-validation or bootstrap 
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sampling, is employed due to the difficulties of obtaining a large number of spectra. The 
five stages are mutually dependent and the best combination of methods to be used at 
each stage must be determined empirically. 
 
2.3.1 Preprocessing 
Biomedical data are notoriously complex and variable. The goal of preprocessing 
methods is to “clean up” the data such that machine learning algorithms will be able to 
tease out key information and correctly classify new samples based on a limited set of 
examples. In analyzing mass spectra of blood samples, the preprocessing stage includes 
two main tasks: noise reduction and normalization.  
In mass spectrometry, the noise is the undesired interfering signal caused by 
sources unrelated to the biochemical nature of the sample being analyzed and the signal is 
the relative abundance of ions originating from the proteins in the sample. Many studies 
to date have not employed explicit noise reduction schemes other than basic noise 
reduction methods implemented on commercial mass spectrometers (e.g., the SELDI-
TOF mass spectrometer from Ciphergen®, Freemont, CA). However, some investigators 
have explored methods for reducing noise, particularly the baseline and high frequency 
noise [35, 63, 67, 68, 71, 73, 103, 127-129].  
Mass spectra exhibit a monotonically decreasing baseline (Figure 1). As described 
above, it is necessary to add a matrix material to the sample of interest. However, it is 
possible for the matrix material to interact with itself as well as with the sample proteins. 
The baseline originates from small clusters of matrix material. Because the chances of 
cluster formation decrease with cluster size, the baseline diminishes monotonically as the 
mass-to-charge ratio increases [117, 119]. The monotonically decreasing baseline can be 
regarded as low frequency noise because the baseline lies over a fairly long mass-to-
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charge ratio range [130]. Most studies that have employed a baseline reduction method 
have taken a two-step approach: baseline estimation followed by subtraction of the 
estimated baseline from the original mass spectrum.  
A variety of approaches have been explored to estimate the baseline from mass 
spectra. Such approaches can be summarized into two major categories: heuristic or 
model-based. Heuristic approaches form non-parametric estimates of the baseline from a 
set of mass spectra. Model-based approaches build a mathematical model of the baseline 
based on the physics of the mass spectrometer and estimate the parameters of the model 
from a set of mass spectra. The baseline estimated by either approach is then subtracted 
from the original spectrum. So far, there have been many more studies using heuristic 
approaches [63, 67, 68, 71, 84, 103] than model-based approaches [129]. 
There have been several studies in which a heuristic approach was used to 
estimate and eliminate the baseline. A local average or minimum intensity within a 
moving window has been used as a local estimator of the baseline and the overall 
baseline is estimated by sliding the window over the mass spectrum [71]. Piecewise 
linear regression has been applied to the regions with a monotonically decreasing 
baseline [67, 68]. The baseline has also been estimated by calculating the convex hull of 
the intensities of the proteins in a region [63]. All these algorithms seem to effectively 
estimate the underlying baseline, at least in some circumstances. However, the 
parameters of these algorithms, e.g., the width of the window in a piecewise linear 
regression model, have been determined in an ad hoc manner. For methods in which a 
sliding window or piecewise linear regression are employed for baseline elimination, the 
window size is a critical factor determining the overall performance. If the window size is 
too large, these methods may oversimplify the curvature of the baseline with a long 
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straight line. If the window size is too small, they may produce an overly complex 
estimate of the baseline, which is very sensitive to high frequency noise. 
There are no absolute standards for deciding which one among the heuristic 
baseline estimation algorithms is more effective than the others; each algorithm has its 
strengths and weaknesses. For example, choosing the minimum peak intensity within the 
sliding window as a local baseline estimator is superior to piecewise linear regression in 
terms of computation time. However, the latter method is expected to be relatively less 
sensitive to high frequency noise than the former one because a straight line with the 
minimum sum of errors between the line and peak intensities within the windows is 
calculated as a local estimator by linear regression. The convex hull is defined as the 
minimal convex set of given objects [131]. Thus, the convex hull of a mass spectrum is 
the piecewise straight lines connecting the local minima on the spectrum. This can be 
easily visualized by imagining a rubber band tightly stretched to encompassing the lower 
side of the mass spectrum. Since the convex hull is calculated based on the local minima, 
it may also suffer from the interference from high frequency noise. 
To the best of my knowledge, there has only been one model-based approach 
reported in the literature to date [129]. Malyarenko et al. used a model for the baseline in 
SELDI TOF was developed using the phenomenon of charge accumulation that decays 
exponentially on the ion detector [129]. Greater emphasis should be placed on model-
based approaches in the future because they may be more effective with limited data sets 
since a priori knowledge is taken into account. 
Mass spectra of blood samples also exhibit an additive high frequency noise 
component (Figure 2.1). The presence of this noise hampers both data mining algorithms 
and human observers in finding meaningful patterns in mass spectra. While several prior 
studies have explored methods for reducing the influence of this high frequency noise 
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[35, 63, 73, 127-129, 132], few have attempted to identify or describe the sources of this 
noise or to determine proper models for its statistical characteristics [103, 118, 119, 130, 
133]. Moreover, to date, no study has used such noise characterization work to develop a 
“model-based” high frequency noise reduction scheme. 
The heuristic high frequency noise reduction approaches employed most 
commonly in studies to date are smoothing filters [35, 63, 132], the wavelet transform 
(WT) [54, 77, 127], or the deconvolution filter [129]. Typical smoothing filters are the 
Gaussian filter [35, 132] and moving average filter [63]. These smoothing filters smear 
out the high frequency noise signal in the spectra by averaging the intensities within a 
moving window. In the case of a Gaussian filter, the intensities are weighted by a 
Gaussian kernel before calculating the average. Over the past decade, the WT has been 
frequently used for chemical/biological signal processing [134, 135]. The WT is a type of 
signal decomposition algorithm that allows us to view a signal as a superposition of 
weighted basis functions with different frequencies and time shifts. The frequency range 
and time location of the high frequency noise are localized using the WT. Then the high 
frequency noise can be effectively reduced by manipulating the weight coefficients of the 
basis functions [54, 73, 127, 134, 135]. The deconvolution filter reduces noise by 
minimizing the sum of squared errors between the desired output and filtered signal and 
the power of filtered noise. In this case, it is assumed that the observed signal can be 
modeled as the sum of the true signal and additive stationary noise [136]. Malyarenko et 
al. applied the deconvolution filter to SELDI TOF mass spectra and reported that it 
reduced noise and improved the resolution [129].  
All of the methods have made considerable contributions to high frequency noise 
reduction in mass spectra. However, since no study has extensively compared the 
methods introduced above on the same data set, it is difficult to conclude if one method is 
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better than the others. Moreover, the overall performance of those high frequency noise 
reduction methods is highly dependent on the choice of the filter parameters (e.g., the 
size of the sliding window or the kernel weights) and the true effectiveness of those 
methods is difficult to measure due to the lack of knowledge on the statistical 
characteristics of the signal and noise in mass spectra.  
Most noise reduction approaches to date have emphasized designing filters based 
on empirical insight rather than rigorous statistical analysis. However, a few studies have 
tried to identify the noise sources in mass spectrometry and to measure the statistical 
characteristics of the noise [103, 118, 119, 130, 133]. Such studies are critical because the 
lack of information on the statistical characteristics of the true signal and the noise may 
lead to the design of filters that remove the desired signal or fail to remove the noise. In 
other words, aggressive filtering may smear out diagnostically informative patterns and 
insufficient filtering may leave high levels of noise in the signal. Because low abundance 
proteins are expected to contain diagnostically useful information, ad hoc noise reduction 
approaches may actually make it more difficult to detect differences in the spectral 
patterns between cancer and healthy samples. Statistical characterization of the individual 
noise components in mass spectrometry can provide the basis for model-based 




Figure 2.2: Normalization is needed in order to compare across spectra since mass 
spectrometry provides a measure of the relative abundance of the different proteins in a 
sample. In the illustration here, the original spectra (A) are normalized such that the 
maximum peak heights in each spectra are the same (B).
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A peak in mass spectra indicates the relative abundance of a protein; therefore, 
the magnitudes of mass spectra cannot be directly compared with each other. 
Normalization methods scale the intensities of mass spectra in order to make mass 
spectra comparable (Figure 2.2). The most frequently used normalization method is 
normalization with respect to the total ion current (TIC), i.e., the sum of all the peaks in a 
mass spectrum [37, 50, 58-60, 62, 71, 75, 80, 83, 137]. Normalization with respect to the 
mean spectrum has also been used, which is equivalent to normalization with respect to 
TIC [35]. Other studies have performed normalization with respect to the largest peak 
[66, 68] or linear scaling using the largest and smallest peak intensities [36, 38, 43, 72]. 
Normalization with respect to one or two peaks within a spectrum may be more sensitive 
to noise than normalization with respect to TIC because the effect of noise at those peaks 
is transferred to all other peaks through normalization while noise will be canceled out by 
the summation of peak intensities in normalization with respect to TIC.  
The four normalization methods described above are performed within a 
spectrum. Normalization across samples has also been investigated. All the peak 
intensities at the same mass-to-charge ratio across samples can be normalized with 
respect to the median peak intensity [74, 79] or linearly scaled using the largest and 
smallest peak intensities [34, 137]. Some investigators have extended simple linear 
scaling by taking the peak variability into consideration [128]. These methods ignore the 
absolute difference in peak intensities at different mass-to-charge ratios and consider only 
the difference in the expression levels between cancer and normal samples. Therefore, 
small peaks can be considered to be as important as large peaks in normalization across 
samples. However, it should be noted that noise embedded in small peaks can also be 
amplified by such normalization methods and it still remains unanswered whether peaks 
belonging to different spectra can be manipulated without any precedent normalization 
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within a spectrum. At present, it is not clear if one normalization method is superior to 
the others since there have not been any studies in which normalization methods were 
compared on the same data set. 
Some studies have investigated the use of the log transform to reduce the 
variability of mass spectra [39, 50, 58, 60, 69, 75, 83, 128]. However, one should be 
cautious in using the log transform since it may make it difficult to separate the additive 
noise component from the original signal. Suppose that mass spectra have additive 
random noise with zero mean. Such noise can easily be reduced by simple averaging; 
however, such noise cannot be reduced by simple averaging after a log transform because 
summation in the log space corresponds to multiplication in the original space. In 
addition to the log transform, the square root transform has also been investigated as a 
means of reducing the variability [75]. 
 
2.3.2 Feature extraction 
Features are variables constructed from preprocessed data to summarize the 
properties of the data [138, 139] and the process of constructing features is called as 
“feature extraction”. In decision support systems utilizing mass spectra, feature extraction 
can be defined as a process of extracting summary information reflecting the pathological 
status of a sample from preprocessed mass spectra. 
The simplest approach to feature extraction from mass spectra is to use the 
abundance (intensity) information of every 
! 
m z  measured as the features [32, 35, 36, 
38-40, 64]. While this approach to feature extraction is straightforward, it places 
additional demand on the feature selection and classification stages since a very large 
number of features are used (≈15,000) and most studies employ a modest number of 
cases (< 500). Moreover, mass spectrometers can only distinguish the masses of proteins 
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within a finite resolution level. More than one 
! 
m z  measured can correspond to the 
same protein. Thus, high levels of correlation are expected between close 
! 
m z  values.  
Some studies have employed binning to extract features from the raw mass 
spectra [43, 55, 56, 71, 72]. The 
! 
m z  points are grouped into a number of bins and a 
feature is derived from each bin by calculating the average [72] or the maximum peak 
intensity [71]. The spacing of bins is usually uneven because the number of peaks is not 
uniformly distributed [72]. Binning is the simplest form of peak detection and alignment, 
which will be discussed in depth from the next paragraph, in the sense that bins are 
defined over the 
! 
m z  axis but they are initially placed at fixed positions across multiple 
spectra and never adjusted again. Binning is also fairly straightforward to use; however, 
care must be taken in determining the size and location of bins because improper binning 
may lead to extraction of features, which do not reflect the pathological status of samples.  
Since abundance data from within the mass error rate are considered to represent 
the same protein, features are often extracted from mass spectra based on the properties 
of “peaks” that are comprised of multiple 
! 
m z  points. In this approach, feature 
extraction consists of three main components: peak detection, peak alignment, and 
calculation of feature metrics. Often, commercial software provided with mass 
spectrometers (e.g., Ciphergen®’s SELDI TOF system) and in-house algorithms are 
combined in the feature extraction process.  
The identification of peaks in a mass spectrum is complicated by the error in 
measuring the abundance as well as the mass error rate. The goal of peak detection is to 
identify sets of 
! 
m z  values which comprise “peaks” that are higher than the noise level 
of a mass spectrum. In many studies, commercial software has been used to find as many 
peaks as possible and a predefined threshold has been applied to select peaks far higher 
than the noise level. For example, Ciphergen ProteinChip® software detects peaks based 
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on the signal to noise ratio (S/N). The S/N is an indicator of how much a peak is 
distinguished from background noise. If the S/N of a peak is 10, the peak has an intensity 
value 10 times larger than background noise. Ciphergen ProteinChip® software first 
selects peaks with a high signal to noise ratio (e.g., S/N ≥ 10) within individual mass 
spectra. Then, across mass spectra, it finds more peaks with a moderately high S/N (e.g., 
S/N ≥ 2) [127, 140]. Some researchers have explored alternative peak detection 
algorithms for more rigorous peak finding [52, 60, 63, 69, 103]. Most peak detection 
algorithms find local maxima within a certain mass-to-charge ratio range and choose the 
local maxima higher than a threshold of the noise level as peaks [52, 60, 68, 103]. Local 
maxima of a mass spectrum are located by finding the mass-to-charge ratios with the 
highest intensity among their N neighbors [52, 103].  
Clearly, peak detection algorithms must include a definition of the noise level 
around a local maximum. The noise level is often defined as the average of the intensities 
at the mass-to-charge ratios within a moving window with a fixed size (e.g., 5% of all 
mass-to-charge ratios in a mass spectrum) [52] or as the median elevated level from the 
median difference of all local maxima and their adjacent local minima in a mass spectrum 
[103]. 
Peak detection, as described above, is concerned with identifying peaks within a 
single mass spectrum. However, in order to make inferences about trends across several 
spectra, one must relate the peaks identified in one spectrum to the peaks identified in 
another spectrum. This process of matching peaks that represent the same protein specie 
across multiple spectra is referred to as “peak alignment” (Figure 2.3). In peak 
alignment, the peaks of multiple mass spectra within the mass error rate are grouped 
together and regarded as a “peak group”.  
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Figure 2.3: The left panel illustrates peak detection, which is concerned with identifying 
peaks within a single mass spectrum. The right panel illustrates the process of matching 
peaks that represent the same protein specie across multiple spectra, which is referred to 
as “peak alignment”. 
 
Most peak alignment algorithms group the peaks around a prominent peak within 
a moving window the size of the mass error rate in a mass spectrum. Then, the peak 
groups within the mass error rate are re-grouped across [37, 49-51, 60, 68, 74, 80, 83, 
132]. In one study, a genetic algorithm was employed to optimize the process of window-
based peak alignment [70]. Peak alignment simply based on the mass error rate can 
produce peak groups that cannot effectively represent proteins in a complex sample. A 
genetic algorithm was used to identify the peaks that were present across the most 
samples while at the same time avoiding those that were within the mass error rate of the 
peaks that were already selected. 
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After peak detection and peak alignment, one must define the metrics of a peak 
group that will serve as features. Feature metrics related to peak heights have been used 
in most studies. The maximum peak height [36, 67], average peak height [72, 80], and 
median peak height of a peak group [76] have been used. Instead of retaining the peak 
height as continuous feature data, binary [52] and discretized feature [66] values have 
also been investigated as a way to alleviate the variability of feature values across 
samples that can deteriorate the generalization of the classifier. Binary feature values 
indicate whether a peak is expressed over the noise level and further discretized feature 
values specify the degree to which a peak is expressed. Some studies have employed the 
sum of peaks in a peak group, i.e., the ion current of a peak group, in order to take into 
account the contributions of all the peaks representing one protein [34, 67]. 
Most feature extraction methods, as described above, extract features from signals 
in the original space, i.e. peak intensities of mass spectra. In a few studies, features were 
extracted by projecting the signals from the original space onto another, usually lower-
dimensional, space through linear transformations. Principal Component Analysis (PCA) 
has been widely used as a standard way for this purpose in many other data mining 
applications [141]. PCA identifies the orthogonal directions in which data vary 
maximally using the eigenvalue/eigenvector decomposition of the covariance matrix. 
Then the original signals are projected onto those directions, the number of which is 
usually smaller than the original dimension. The projections are called principal 
components and often used as features. Since only those directions that explain data 
variation maximally are selected in PCA, the projected data is of a lower dimension, but 
with a minimum loss of information. In one study, every 
! 
m z  point was regarded as a 
dimension and PCA was applied to find principal components, which were used as 
features in clustering analysis [73]. The WT has been also employed not only to reduce 
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noise but also to extract features from mass spectra in a similar fashion as PCA is used 
[54, 77]. The WT also compresses data by projecting the original data onto prespecified 
orthogonal directions (wavelets). The coefficient of each wavelet becomes a feature in 
this case [54, 77]. Since the wavelets representing high frequency components are usually 
ignored, noise reduction is simultaneous accomplished with feature extraction. Both 
approaches are very sensitive to the choice of components (i.e., principal eigenvectors in 
PCA or wavelets in the WT); therefore, it is important to determine criteria for selecting 
eigenvectors or wavelets prior to feature extraction. However, this is currently performed 
in an ad hoc manner. In addition, as compared with methods that select features in the 
original space, the features resulting from PCA or the WT are less interpretable because 
the features are extracted from the projected space. Thus, the inverse transformations are 
needed to reveal how features (
! 
m z  points) in the original space contribute to creating 
each feature in the projected space. 
In feature extraction, a variety of peak detection and alignment algorithms are 
being developed and tested. The resolution and noise of mass spectrometry systems 
should be taken into account. For example, using the maximum peak of a peak group 
might lead to over/underestimation of relative abundance of a certain protein because it 
can be easily affected by noise. Likewise, peak alignment that only considers the mass 
error rate might deteriorate the sensitivity and specificity. It is possible that better 
diagnostic systems could be developed if more prior knowledge of mass spectrometry 
and the proteins present in blood was incorporated into the feature extraction process.
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Figure 2.4: Feature selection methods are often categorized as filters (top panel), 
wrappers (middle panel), or embedded methods (bottom panel). A filter method evaluates 
and ranks individual features based on selection criteria (e.g., t statistic). Then, a subset 
of features for classification is determined based on individual feature ranks. Wrappers 
assess the relevancy of a subset of features based on evaluation metrics of a classifier 
trained using that subset of features. Embedded methods implicitly perform feature 
selection as a part of the classifier training process (e.g., decision tree). 
2.3.3 Feature selection 
The purpose of feature extraction is to produce a set of quantitative measures 
from a mass spectrum that could potentially be used for distinguishing spectra of normal 
and cancer samples. Typically, the feature extraction process results in a smaller set of 
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features (< 1000) than the number of (
! 
m z , relative abundance) pairs that were in the 
original spectrum (≈15,000). However, in general, the number of features extracted is still 
much larger than the number of samples (< 500) in an experiment. This imbalance in the 
number of features and samples may increase the chances of misclassification due to 
overtraining and the usage of irrelevant or redundant features [41, 139, 142-144]. Also, a 
large number of features usually leads to an increase in the training time of classifiers. 
Moreover, from a biomedical perspective, it is important to find a moderate number of 
proteins that most contribute to correct classification such that these potential biomarkers 
can be identified and biochemically validated. Thus, it can be important to reduce the 
number of features from the set initially extracted. This process is referred to as feature 
selection. 
Feature selection is defined as a series of actions to choose a subset of features 
that are relevant to correct classification based on specified evaluation and selection 
criteria [40, 139, 142, 144]. Feature selection methods are often categorized as filters, 
wrappers, or embedded methods (Figure 2.4). A filter method evaluates and ranks 
individual features based on selection criteria (e.g., t statistic). Then, a subset of features 
for classification is determined based on individual feature ranks. Wrappers assess the 
relevancy of a subset of features based on evaluation metrics of a classifier trained using 
that subset of features. A search algorithm is used to explore the space of feature subsets 
and identify a high-performing subset of features. Cross-validation or bootstrap sampling 
is used in conjunction with wrapper methods since they can provide unbiased accuracy 
estimates of the classifier. Embedded methods implicitly perform feature selection as a 
part of the classifier training process. 
Filters have been the most commonly used type of feature selection in prior 
studies of cancer classification using mass spectra. A variety of statistical tests have been 
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investigated to define selection criteria for the relevancy of individual features. The two-
sample t test has been used in many studies [35, 37, 64, 79, 84, 85, 145]. A t test for two 
independent samples (cancer, normal) is performed on each feature across the training 
samples and features that show a statistically significant difference (e.g., p < 0.05) in the 
group means are selected for use in training classifiers. Other studies have also used 
methods related to the t test for two independent samples. Li et al. define the distance 
between two sample groups, cancer and normal, as the absolute mean difference 
normalized by the root mean square of the variances of two sample groups [40]. This 
distance measure resembles the two-sample t test for independent samples with unequal 
variance. Zhu et al. calculated a reliable threshold for p value based on 1 D Gaussian 
random field considering the fact that multiple comparisons are made [35]. Other types of 
statistical tests such as the t  test [82, 145], the one-way analysis of variance (ANOVA) 
[49, 68], the Wilcoxon signed rank test [38, 47, 65, 80] and the Mann-Whitney test [65] 
have also been used to rank features.  
Some studies have tested the efficacy of relevancy measures on the basis of 
information theory and signal processing as filters. Information gain and relief-F [142, 
146] are examples of measures used in information theory based filters [66]. The wavelet 
transform can also be used as a filter method for feature selection. In one study, features 
were assessed by comparing the wavelet coefficients of each feature between cancer and 
normal samples [77]. Receiver operating characteristics (ROC) analysis [147] has also 
been used to measure the relevancy of an individual feature. The area under the curve of 
each feature is calculated and it is used as the metric to rank features [51]. ROC analysis 
is discussed further in the evaluation section. 
Using a single relevancy measure can lead to biased feature selection. Thus, 
combinations of methods have been investigated for feature selection [37, 70, 80]. A 
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feature is considered to be relevant when the feature receives high scores from multiple 
methods. This approach enables one to explore features from different perspectives and 
to make a more reliable decision regarding the selected subset of features. 
Wrappers are different from filters in that classifier evaluation metrics are used 
rather than selection criteria for individual features and wrappers assess features in 
groups rather than individually. Filters employ selection criteria such as statistical tests to 
evaluate individual features, while wrappers use evaluation metrics of classifiers to 
estimate the discriminating power of a candidate subset of features [139, 142-144]. 
Moreover, while filters simply select a subset of features by choosing those that were 
highly ranked individually, wrappers iteratively optimize the subset selection using 
search algorithms such as genetic algorithms and stepwise selection methods [139, 142-
144]. The wrapper approach typically has better performance than the filter approach 
since the search process in wrappers enables it to exclude redundant features when 
forming a subset of features [139, 142]. However, the filter approach does have the 
advantage that it is less computationally demanding than the wrapper approach [40, 142].  
Several studies have investigated the efficacy of wrappers for feature selection in 
mass spectra. The combination of genetic algorithms [146] with classifiers is a popular 
use of wrappers in this field [36, 40, 71]. Several kinds of classifiers have been combined 
with genetic algorithms, including self-organizing maps [36, 42, 43, 56], support vector 
machines (SVM) [40], and simple distance based classifiers (e.g., Mahalanobis distance) 
[54, 71, 84]. In other studies, stepwise feature selection methods (forward selection and 
backward elimination) [139] have been used instead [38, 67]. A wrapper that incorporates 
unified maximum separability analysis (UMSA) and bootstrap sampling has identified 
the best performing subset of features in three studies [50, 58, 83].  
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Embedded methods implicitly perform feature selection as a part of the classifier 
training process [139]. For example, decision trees estimate the contribution of individual 
features to correct classification in each iteration and grow the tree structure according to 
the estimation result. Therefore, when the training is over, the final subset of features is 
produced with the classifier [139, 146]. Feature selection using embedded methods for 
mass spectra will be further discussed in the next section on classification. 
Feature selection can help to reduce running time and avoid overtraining if it 
succeeds in finding a subset of independent and discriminating features. Unfortunately, 
there is no guarantee that the feature selection process will improve the classification 
performance. Moreover, features selected as relevant for classification still need to be 
biologically validated in future studies. Efforts to identify the proteins corresponding to 
relevant features should follow feature selection and classification studies. 
 
2.3.4 Classification 
Machine learning is a branch of artificial intelligence that is concerned with 
design and application of algorithms that enable computers to learn from experience 
[146]. I interpret this definition broadly to include techniques that were developed from a 
statistical, rather than computer science perspective, such as linear discriminant analysis 
and regression.  
There are three general types of machine learning algorithms: unsupervised, 
reinforcement, and supervised. In unsupervised learning, the computer attempts to 
identify natural groupings within a dataset based on criteria that define how “similar” 
items are and what makes a “good” group, but without being provided examples of the 
feature values of items and associated “correct” class membership. For this reason, 
unsupervised learning methods are also referred to as “clustering”. Unsupervised learning 
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algorithms have not been used in many prior studies of cancer diagnosis from mass 
spectra. Some studies have explored self-organizing maps [36, 42, 43, 55, 56] and 
hierarchical clustering algorithms [60, 75, 79] in this field. In reinforcement learning, the 
computer is not provided with examples of the feature values of items and associated 
“correct” class membership, but is provided less specific feedback that indicates if the 
system is on the right track. I am unaware of any studies of mass spectra for cancer 
diagnosis that employ reinforcement learning methods. In supervised learning, the 
computer is provided with examples of the feature values of items and associated 
“correct” class membership. The goal of supervised learning is to develop a “classifier” 
that can predict the class membership from a set of pre-determined classes for an item 
based on a set of features that describe the item. Supervised learning methods have been 
used extensively in the investigation of cancer diagnosis from mass spectra. Prior studies 
have tested the performance of several supervised learning algorithms including artificial 
neural networks (ANN) [66, 76, 79, 89, 137] [148], k nearest neighbor (KNN) [35, 49, 
66, 68, 137], logistic regression [37, 50, 58, 67, 83], decision trees [51, 59, 66, 67, 72, 77, 
86, 137], linear or quadratic discriminant analysis (LDA/QDA) [39, 48, 49, 54, 67-69, 
71], support vector machines (SVMs) [39, 40, 68, 137], matching pursuit (KMP) [63], 
logical analysis of data (LAD) [33], stepwise discriminant analysis [38], partial least 
square projection [73, 75], Naïve Bayes [66], rule induction [66], and ensemble 
algorithms (e.g. boosting, bagging, or random forest) combined with various base 
classifiers [32, 39, 52, 53]. Two evolving themes in the use of supervised learning in this 
field are the emphases on SVMs and ensemble methods. 
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Figure 2.5: SVMs are a type of kernel learning methods, which project data from the 
current vector space to another vector space where linear learning algorithms can be 
applicable. SVMs guarantee the maximal margin between cancer and normal samples 
through global optimization of the decision boundary such that overtraining can easily be 
avoided (margin indicated by arrow). Since the decision boundary set by SVMs has the 
gradient that allows for the maximum-margin separation based on a few data samples 
closest to the decision boundary, which are called support vectors (highlighted with 
gray), SVMs implicitly reflect the contribution of each feature to successful classification 
and reduce the effect of irrelevant features by performing the dot product between the 
gradient and each sample. 
SVM is a fairly new class of supervised machine learning methods that has 
generated considerable excitement (Figure 2.5). SVMs are a type of kernel learning 
methods, which project data from the current vector space to another vector space where 
linear learning algorithms can be applicable. The functions that project the data onto the 
new vector space, which usually has a higher dimension than the original, are called the 
kernel functions. Since an improper kernel function may worsen classification by 
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projecting data onto a space where linear separation is impossible, care must be taken for 
choosing a kernel function when using SVMs. Unfortunately, there are no guidelines for 
choosing the best kernel for a given data set. Prior knowledge of the characteristics of 
data may help with this process, but in practice selecting an optimal kernel remains a 
significant challenge. The most popularly used kernel functions are the polynomial, radial 
basis function, and sigmoid kernels.  
After data projection into a linear space, SVMs guarantee the maximal margin 
between cancer and normal samples through global optimization of the decision 
boundary such that overtraining can easily be avoided [149, 150]. In the cases were the 
projected data is still not linearly separable, for example, when two classes overlap, a 
penalty is given to the objective function of optimization to trade the margin size and 
misclassification rate. A small penalty maximizes the margin size but increases the 
misclassification rate while a large one decreases the margin size but minimizes the 
misclassification rate [151]. 
 SVMs can also be utilized without any data projection if the data are linearly 
separable in the current vector space. This method is usually called linear-SVMs. Since 
the decision boundary set by SVMs has the gradient that allows for the maximum-margin 
separation based on a few data samples closest to the decision boundary, which are called 
support vectors, SVMs implicitly reflect the contribution of each feature to successful 
classification and reduce the effect of irrelevant features by performing the dot product 
between the gradient and each sample. There is less need for an effective feature 
selection step when a classifier that is robust to irrelevant features is used. The robustness 
of SVMs to irrelevant and redundant features is especially valuable since mass spectra 
data sets typically have many more features than cases. Thus, SVMs exhibit several 
properties that are appealing in the analysis of mass spectra. 
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The complexity and subtlety of mass spectra patterns between cancer and normal 
samples may increase the chances of misclassification when a single classifier is used 
because a single classifier tends to cover patterns originating from only part of the sample 
space. Therefore, it would be beneficial if multiple classifiers could be trained in such a 
way that each of the classifiers covers a different part of the sample space and their 
classification results were integrated to produce the final classification.  
Ensemble algorithms such as bagging, boosting, or random forests improve the 
classification performance by associating multiple base classifiers to work as a 
“committee” for decision-making [152, 153]. Any supervised learning algorithm can be 
used as a base classifier. Ensemble algorithms not only increase the classification 
accuracy, but also reduce the chances of overtraining since the committee avoids a biased 
decision by integrating the different predictions from the individual base classifiers.  
Feature selection has been performed as an “embedded” part of the training 
process in many studies, especially when decision tree or SVM methods were used. 
Decision trees select the most discriminant features based on the information gain at each 
stage when growing the tree structure. As a result, a list of features that make the largest 
contributions to successful classification are obtained when classifier training is finished. 
In some studies of cancer classification using mass spectra, features selected implicitly by 
decision trees have been proposed as potential biomarkers [51, 53, 86]. SVMs also 
possess embedded feature selection mechanisms. As described in the earlier part of this 
section, the decision boundary includes the information of each feature’s relevancy for 
successful classification. For example, in the case of the linear SVM, the absolute 
magnitude of coefficients of the decision boundary (a hyperplane) corresponds to the 
degree of relevancy of features. Prados et al. proposed a list of potential biomarkers using 
the internal feature selection function of a linear SVM [137].  
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The goal is to build reliable classifiers, which can classify unknown samples 
within a reasonably bounded error range. While the error of a classifier on the training set 
decreases as the training process proceeds, the error on the general population increases 
after a certain time point in the training process because the classifier becomes 
oversensitive to the patterns that exist only in the training set. This event is called as 
“overtraining.” It is important to avoid overtraining by evaluating the classifier 
performance using an independent set of samples. In addition, it is impossible to find a 
classification algorithm superior to the others for all feature selection methods because 
every classification algorithm has its own learning bias [138, 146]. The performance of a 
classification algorithm can be varied by the choice of feature selection methods. For 
example, KNN is very sensitive to irrelevant and redundant features. However, in prior 
studies, the relationship between the chosen feature selection method and classification 
algorithm has not been thoroughly researched. It is necessary to identify the best pair of a 
feature selection method and classifier. 
 
2.3.5 Evaluation 
After a system is developed through the stages described in the previous sections, 
its performance must be carefully assessed. In this section I discuss two important issues 
in system evaluation. First, the quality of the data set used to develop the system will 
strongly influence its performance since systems for cancer diagnosis from mass spectra 
are inherently data-driven. Second, the system evaluation must be based on criteria that 
are clinically relevant and quantitative with clearly defined standards of interpretation. 
The desired characteristics of the data are that they provide an accurate 
representation of the population to be tested and that there are sufficient data to allow for 
robust inference. There are many factors that can bias a sample such that it doesn’t 
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correctly describe the population, e.g., the choice of human subject inclusion/exclusion 
criteria, data entry errors, etc. This problem is complicated by the fact that disease cases 
typically must be present in the data set at a much higher proportion than the population 
prevalence in order to show the breadth of variability in the disease state with a limited 
overall sample size. The imbalance in the sizes of disease and healthy classes can make 
classifiers more sensitive to patterns originating from disease cases, resulting in more 
false positives in classification. If there are more healthy cases, the number of false 
negatives will increase because patterns from healthy cases will be relatively more 
emphasized. From this point of view, it is valuable to equalize the class sizes [154-156].  
However, there would be difficulty in keeping the balance between disease and 
healthy sample sets as one attempts to increase the entire sample size for more robust and 
reliable inference because disease cases are usually more difficult to obtain than healthy 
ones. To the best of my knowledge, this issue has not yet been addressed in the arena of 
analyzing mass spectra. Over-sampling the minority class or under-sampling the majority 
class are common methods to resolve biased classification due to imbalanced data. The 
basic idea behind these techniques is to balance the sizes of two classes artificially. For 
example, over-sampling the minority class, i.e., sampling with replacement, increases the 
size of the minority class up to that of the majority class. Similarly, under-sampling the 
majority class, i.e., decimating samples, can reduce the size of the majority class up to 
that of the minority class. However, it should be noted that these two techniques must be 
carefully used because over-sampling a minority class may lead to overtraining to a 
specific pattern of the samples belonging to the minority class and under-sampling a 
majority class may lose some valuable patterns of majority class samples [154, 155]. 
Some studies have tried to resolve this issue by penalizing the error rates of the samples 
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of the minority class more, which prevents the classifier from sacrificing those samples of 
the minority class to decrease the overall error rates (e.g. 1-accuracy) [154-156].  
Proper handling of mislabeled data samples is also an important issue for 
classifier training and evaluation. There are two approaches to contending with 
mislabeled data. One is to reduce the likelihood of its existence through experimental 
design and quality control. The second is to eliminate mislabeled data in post hoc fashion 
during the analysis. In practice, since even extremely rigorous experimental design and 
quality control may not be able to perfectly prevent the occurrence of mislabeled data, 
both approaches should be taken in order to alleviate the effects of mislabeled data on 
decision support systems [157-159]. 
In order to avoid mislabeled data through experimental design and quality control, 
one must consider the possible sources. For example, mislabeling can arise from data 
entry errors. To a large extent, this can be avoided through rigorous lab protocols. A more 
concerning source of mislabeled data is genuine confusion regarding the correct 
classification of a sample due to the error or limitations inherent to the diagnostic test 
used to establish truth or the absence of a test for truth. For example, a healthy sample 
may be mislabeled as positive based on a false-positive biopsy. This type of error can be 
avoided if samples are only included for study if they have undergone confirmatory 
testing (e.g., repeated biopsy). On the other hand, a diseased sample can be mislabeled as 
healthy either because of a false-negative diagnostic test or because no diagnostic testing 
was performed (e.g., an asymptomatic subject was presumed to be healthy). Given the 
limitations of existing diagnostic tests for detecting very early stage disease and the many 
reasons not to perform diagnostic tests on seemingly healthy individuals, this can be an 
important source of false-negative samples. The most common approach to avoid this 
problem is to only consider a healthy sample to be healthy after an appropriate duration 
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of disease-free follow-up time [160]. To the best of my knowledge, this issue has not 
been explicitly discussed in any reports of studies of cancer classification from mass 
spectrometry to date. Moreover, I am unaware of any studies that have demonstrated and 
analyzed the risk of system performance degradation due to mislabeled training/test data 
samples in the context of mass spectrometry analysis.  
The machine learning literature can provide some guidance on post hoc methods 
for detecting mislabeled samples. Mislabeled samples may appear as outliers. Therefore, 
detecting mislabeled samples is closely related to detecting outliers. Some approaches for 
outlier detection have been developed. For example, simply analyzing the means and 
standard deviations of features with the confidence intervals of each feature can reveal 
outliers [159] because samples lying outside the confidence interval are highly probable 
to be outliers. Clustering algorithms also can be used to identify outliers [159, 161]. 
Presumably, samples belonging to the same class would be clustered together while 
outliers would behave as ones belonging to other classes. Note that this clustering should 
be performed prior to feature selection. Other studies have used multiple classifiers of 
different types to filter out outliers [162, 163]. The key idea is that the samples whose 
labels were consistent with the labels predicted by multiple classifiers were regarded as 
correct samples and that were not were regarded as outliers.  
There is no theory to provide firm guidance on the sample sizes required to 
properly perform any of the stages of development of clinical decision support systems 
utilizing mass spectrometry of blood products. Sometimes, it is easy to identify in 
retrospect that a sample may have been too small, such as when an algorithm fails to 
converge or operates with unacceptably low performance. However, one needs to take 
care in devising evaluation strategies that help avoid the common and difficult problem 
of the system appearing to perform well on the data set used for development but proving 
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unsatisfactory when subjected to additional testing with more data. Fortunately, this 
danger can be reduced to a large degree through appropriate use of data partitioning and 
sampling schemes. 
In general, three independent sets of samples are needed for the development and 
evaluation of a classification system [146]. One set is called the training set and used for 
training a classifier. During or after classifier training, the classifier should be pruned and 
adjusted to avoid possible overtraining using another, independent sample set, which is 
referred as the validation set. As described in the previous section on classifier training, 
the error on the validation set tends to increase after a certain time point while the error 
on the training set keeps decreasing as the training process continues. The time point at 
which the error on the validation set starts to increase is the point when training should 
conclude. The validation set is used to find the stopping point of training. After the 
classifier is developed using the training and validation sets, it must be evaluated with 
respect to the general population. The test set is used to estimate the true error of the 
classifier on the general population. It is also important to recognize that a mass 
spectrometry analysis is actually composed of a series of chemical/biochemical 
processes. Thus, within a data set samples must be randomized at each analytical step so 
as to avoid any possible bias due to batch processing because such bias could produce 
systematic patterns that interfere the “true” patterns originating from the pathological 
changes in the samples.  
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Figure 2.6: The left panel illustrates k-fold cross-validation and the right panel illustrates 
bootstrap sampling. In k-fold cross-validation, the data are split into k non-overlapping 
subsets or “folds” such that each sample is present in a single fold. The classifier is 
trained on k-1 of the folds and tested on the remaining fold. This process is repeated such 
that each fold is withheld once. Usually, the average of evaluation results (e.g., 
accuracies) across the folds is taken as the estimate of the overall system performance. 
By comparison, a bootstrap set is created by random sampling of N cases with 
replacement from the original set of N cases. A classifier is trained on one such bootstrap 
set and tested on another. The process is repeated many times and the average of the 
evaluation results across the bootstrap sets is taken as the estimate of the system 
performance. 
Typically, the same data (training set) are used in the procedures of preprocessing, 
feature extraction, feature selection, and classifier training. The use of separate sets for 
choosing algorithms and setting their parameters in each of these stages would provide 
greater protection against overtraining. Unfortunately, this is seldom plausible given 
realistic sample sizes. In fact, in most studies of cancer classification using mass spectra, 
the number of available samples is not even large enough to produce three independent 
sample sets. Even when three non-overlapping sets are used, they are typically partitioned 
from a single set and as such as are not truly “independent” sets. I am aware of very few 
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studies of cancer classification using mass spectra of human blood samples that have 
employed a truly independent test set (e.g., test set was generated on a different day than 
the training set) [35].  
The small number of cases necessitates the use of sampling techniques such as k-
fold cross-validation, bootstrap sampling [164-166], or random partitioning (Figure 2.6) 
to estimate the generalization ability of the classifier. Sampling techniques are used to 
obtain estimates of classifier performance by judicious reuse of data. However, it should 
be noted that no sampling technique can perfectly address the question of how systematic 
and realistic variations in the data source (e.g., variations in a single mass spectrometer 
over time or between two mass spectrometers) will impact the general classifier 
performance. A classification system must ultimately be evaluated using a large, 
independent data set.  
In k-fold cross-validation, the data are split into k non-overlapping subsets or 
“folds” such that each sample is present in a single fold [164]. The classifier is trained on 
k-1 of the folds and tested on the remaining fold. This process is repeated such that each 
fold is withheld once. Usually, the average of the evaluation results (e.g., accuracies) 
across the folds is taken as the estimate of the overall system performance [32, 33, 39, 42, 
49, 53, 54, 58, 59, 62, 63, 66, 67, 69, 77, 79, 83, 86, 137]. When k is equal to the number 
of samples, this procedure is called leave-one-out cross-validation. In leave-one-out 
cross-validation, every sample is tested exactly one time and the overall system 
performance is estimated by simply gathering the individual sample validation results as 
if these test results came from a single classifier [33, 35, 40, 41, 69-73, 75, 77]. Note that 
the actual number of classifiers trained is equal to the value of k in the cross-validation.  
It is important to remember that the performance estimates obtained by k-fold 
cross-validation are affected by the size of the training set and the number of folds. An 
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estimator is evaluated in terms of its bias, the extent to which the average system 
performance estimate is close to the true system performance in the population, and its 
variance, the extent to which the estimates spread around the average system 
performance estimate [167]. The estimate of the true system performance is more biased 
as the size of the training set decreases and has higher variance as the size of the testing 
set decreases [168, 169]. Therefore, a cross-validation using a larger value for k will 
result in an estimate with less bias, but higher variance relative to a cross-validation using 
a smaller value for k. Several excellent texts are available that discuss the trade-offs 
between bias and variance in classifier evaluation [138, 167-169]. 
The bootstrap sampling is another technique to estimate the true system 
performance with a limited number of samples [164, 165]. A bootstrap set is created by 
random sampling of N cases with replacement from the original set of N cases. A 
classifier is trained on one such bootstrap set and tested on another. The process is 
repeated many times and the average of the evaluation results across the bootstrap sets is 
taken as the estimate of the system performance [39, 42]. Note that each bootstrap set 
created for training results in a separate classifier. One study [39] employed 0.632+ 
bootstrap sampling, a modified version of bootstrap sampling, which can alleviate the 
bias in estimating the true system performance [168]. 
Random partitioning can be regarded as single or multiple 2 fold cross-validation. 
It is also similar to bootstrap sampling except that sampling is performed without 
replacement and less than N of N cases are selected. The training set is generated by 
randomly sampling a certain portion of data and the remaining samples of data are used 
as the test set [36-38, 42, 48, 51-56, 62, 67, 70, 80]. 
Commonly, cross-validation, bootstrap sampling, and random partitioning are 
used to estimate the system performance during the classifier training stage. However, 
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some studies have applied random partitioning to derive reliably discriminant features 
during feature selection [50, 58, 80, 83] based on the ranks of discriminant features that 
are earned on each sampled training data set. The features with consistently high ranks 
are selected for use. However, in practice, it is often impossible or very difficult for the 
entire design process to be performed in a cross-validation manner. As a consequence, 
several previous studies seem to have used the full data set prior to cross-validation for 
feature selection [39, 48, 68, 69, 72, 79, 83]. As was the case for estimating system 
performance, sampling techniques cannot overcome limitations that are inherent to the 
data set from which the samples are drawn. If the data set does not represent the 
underlying probability distribution of the population of interest, then even the most 
sophisticated feature selection methods based on sampling techniques will end up with an 
extremely “biased” subset of features [160]. 
It is critical that the system evaluation be based on criteria that are clinically 
relevant and be quantitative with clearly defined standards of interpretation. While 
classifiers typically attempt to optimize an evaluation function as part of the training 
process, it is important recognize that in general that function is not the most clinically 
relevant measure. For example, the mean-square error measure weights the two possible 
kinds of error equally while in most medical diagnostic tasks the costs, monetary and 
otherwise, of false-positives and false-negatives are not equal.  
Accuracy, the fraction of the samples that the system correctly classifies, has been 
used in many mass spectrometry studies that employ a binary decision approach [32, 37, 
39-41, 48, 49, 63, 66-68, 70-73, 75, 77, 87, 89, 137, 148]. However, there is a significant 
drawback to the accuracy metric in that it is dependant on the prevalence of disease in the 
data set. For example, if there are only 20 disease cases for every 80 normal cases, a 
system could achieve 80% accuracy by simply reporting all cases as normal. Thus, if the 
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prevalence is not 50%, the system accuracy can’t be interpreted in isolation. The most 
clinically relevant measures for screening and diagnostic tests are sensitivity and 
specificity, regardless of whether the test involves a computational aid. Many studies of 
mass spectrometry for cancer classification have used these measures [33, 35-38, 43, 47, 
48, 50-55, 58, 59, 62, 68, 69, 72, 79, 80, 83, 84, 86, 105, 137, 145].  
Receiver Operating Characteristic (ROC) analysis can be used for diagnostic 
systems that provide a range of outputs rather than a binary classification. An ROC curve 
is a plot of the sensitivity vs. (1-specificity), or equivalently the true positive fraction vs. 
the false positive fraction, computed from the application of a series of thresholds to the 
system output (Figure 2.7). The advantage of ROC analysis is that it explicitly shows the 
tradeoffs in sensitivity and specificity that could be achieved with the same classification 
system. In essence, the choice of the decision threshold is delayed until a later time when 
more knowledge may be available on the costs associated with each type of error. 
 In general, ROC curves are concave and better system performance corresponds 
to more concave curves. A measure of the concaveness of ROC curves is the area under 
the curve (AUC). Hence, the AUC has been used as a measure of system performance in 
many studies [37, 40, 58, 69, 72, 80, 83, 86, 137, 148]. 
Evaluation metrics (e.g., ROC AUC) are calculated based on a given data 
samples, yet it is the performance on the general population that matters. Therefore, there 
is a need to estimate the reliability of the system. For this purpose, some studies have 
randomly permuted the class labels of samples and compared the performance to that 
from using the actual class labels [49, 67, 68, 73]. As the difference between two 
becomes larger, the performance evaluation from the actual samples is taken as a more 
reliable indicator of how the system would perform on the general population. 
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Figure 2.7: Receiver Operating Characteristic (ROC) analysis can be used to evaluate 
diagnostic systems that provide a range of outputs rather than a binary classification. An 
ROC curve is a plot of the sensitivity vs. (1-specificity), or equivalently the true positive 
fraction vs. the false positive fraction, computed from the application of a series of 
thresholds to the system output. A measure of the concaveness of ROC curves is the area 
under the curve (AUC). 
When sampling techniques are used, care must be taken not to mistakenly tune 
classifier performance results on the “testing” portions. For example, several studies 
appear to have determined the threshold for calculating the sensitivity and specificity 
based on the “testing” portion of the data rather than the “training” portion [37, 40, 48, 
58, 69, 72, 79, 80, 83]. These practices can partially undermine the protection against 
overtraining provided by those sample techniques.  
The use of appropriate data sampling methods and relevant evaluation metrics can 
provide substantial reassurance that laboratory studies will contribute towards the goal of 
accurate and reliable clinical decision support systems. Of course, laboratory studies must 
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be followed by rigorous clinical testing. For example, studies of the way that the 
healthcare team does, or does not, incorporate the recommendations made by a system 
based on the mass spectrometry data are beyond the scope of this review. Ultimately, 
long-term, large clinical trials are required to establish the efficacy of any screening test 
to the level of a decrease in cause-specific mortality. 
 
2.4 SUMMARY 
An ideal screening method should be accurate, reliable, rapid, inexpensive, and 
minimally invasive. Proteomic profiling of blood samples using mass spectrometry has 
recently been proposed as a method that has the potential to meet these goals. However, 
there are key difficulties that must be addressed before clinical diagnostic tools can be 
developed based on this technology. Chief among these is to overcome the restrictions on 
reliability that have plagued early studies. To achieve accurate classification on a given 
set of samples is useless unless the classifier can also be generalized such that new, but 
similar, data can be accurately classified. A system for discriminating proteomic patterns 
of samples from healthy and ill people must be robust to the variability that will exist 
across people, mass spectrometers, sample collection protocols, days, etc. 
This chapter reviews the literature on developing clinical decision support 
systems for cancer screening from proteomic patterns obtained by mass spectrometry of 
blood samples from a machine learning perspective. Prior studies are presented in an 
explicit machine learning framework consisting of five stages: preprocessing, feature 
extraction, feature selection, classifier training, and evaluation. The purpose of 
preprocessing is to reduce the influence of aspects of the data that are not expected to aid 
in the goal of discrimination between disease and healthy patterns and instead may make 
that classification task more difficult. In feature extraction, the aim is to reduce the 
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dimensionality of the data and increase the interpretability by defining numerical 
summary measures, often called “features”. Following feature extraction, it is necessary 
to perform a feature selection step in which a subset of features that best enable 
discrimination between the two groups is identified. Given a set of spectra summarized 
by informative features and with corresponding truth (health status), a variety of 
classification algorithms can be trained. Finally, care must be taken in the choice of 
experimental design (e.g., data sampling) and evaluation criteria in order to assess both 
accuracy and reliability (generalization).  
It is apparent that the components of the framework that are most specific to the 
data type, mass spectra of blood samples, are preprocessing, feature extraction, and 
feature selection. I hypothesize that improvements in these components will yield the 
greatest increase in system reliability and that the approaches most likely to achieve those 
improvements will be based on explicit models of the data generation. While the 
objective of developing a clinical decision support system for cancer screening from 
proteomic patterns is ultimately data driven, I argue that this goal may not be achievable 
with reasonable sample sizes unless knowledge of the related biology, chemistry, and 
engineering is used to constrain the design process. 
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Chapter 3: ANALYSIS OF NOISE FROM INSTRUMENTATION IN 
MALDI TOF MASS SPECTROMETRY 
3.1 INTRODUCTION 
In recent years, matrix-assisted laser desorprtion/ionization time-of-flight 
(MALDI TOF) MS and its variants (e.g., surface-enhanced laser desorption/ionization 
time-of-flight MS) analyzed with computational pattern recognition algorithms have 
attracted attention as tools for early diagnosis of cancer. The key role of MALDI TOF or 
SELDI TOF MS for early cancer diagnosis is to identify differences due to pathological 
changes between the mass spectra of diseased samples and those of controls so that 
pattern recognition algorithms can learn statistically dissimilar patterns. However, 
because most such pattern differences in mass spectra of samples such as plasma/serum 
are very subtle, noise can cause false positives or false negatives in peak detection by 
distorting the true shape of the mass spectrum. Thus, several studies have investigated 
methods for characterizing or reducing noise in order to improve the sensitivity of MS 
[35, 54, 63, 67, 68, 71, 73, 77, 103, 118, 119, 128-130, 132, 133, 170-173]. 
To date, most efforts for noise reduction, particularly in MALDI TOF MS, have 
focused on eliminating the baseline and reducing high frequency noise [35, 63, 68, 71, 
73, 128, 129, 170, 172, 173]. The baseline is a monotonically decreasing bias in the mass 
spectrum that originates from matrix clusters formed during the ionizing process. To 
eliminate this baseline, it is heuristically estimated [63, 67, 68, 71, 103] and then 
subtracted from the original mass spectrum. For the baseline estimate, a local average or 
minimum intensity within a moving window [71], a piecewise linear regression line [67, 
68], or the convex hull of the intensities [63] have often been used. On the other hand, 
high frequency noise appears in the mass spectrum as fast varying ripples or irregular 
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peaks. A number of factors such as electrical interference, random ion motions, statistical 
fluctuation in the detector gain, or chemical impurities may be involved with the 
occurrence of the high frequency noise. Heuristic approaches have been predominantly 
used to reduce high frequency noise. For example, moving average filters [63], Gaussian 
kernel filters [35, 132], principal component analysis (PCA) [172], and the wavelet 
transform (WT) [54, 77, 170] are common techniques for high frequency noise reduction. 
Andreev et al. obtained power spectral density estimates of the high frequency noise 
through non-parametric power spectral density estimation and designed a matched filter 
to reduce the noise adaptively [171]. Most manufacturers also provide noise reduction 
algorithms such as a moving average filter in their products; however, it is difficult to 
obtain optimal filtering results because the users must determine the filter parameters 
iteratively through experimentation or based on previous experience.  
The noise reduction approaches introduced above have been established based on 
empirical insight rather than on rigorous statistical noise analysis; therefore, the 
parameters of these algorithms have been determined in an ad hoc manner. Few studies 
have investigated the noise sources in MS or attempted to model the noise by measuring 
its statistical characteristics. Anderle et al. attempted to represent the noise magnitude 
variance in liquid chromatographic MS (LC MS) as a combination of quadratic and linear 
models [133]. Similarly, Hastings et al. fitted the log transformed noise level to a sum of 
two normal distributions, and compared the performance of the average and median 
filters based on their noise model [173]. However, since these studies were not preformed 
from a stochastic signal processing perspective, they do not provide sufficient instinct on 
how noise varies with time and frequency. Malyarenko et al. developed a numerical 
baseline model using the phenomenon of exponentially decaying charge accumulation on 
the ion detector [129]. I proposed a noise model for MALDI TOF MS, where I 
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categorized noise into three types: noise from instrumentation, noise from random ion 
motions, and chemical noise [108, 130]. Then, I hypothesized that the observed noise is a 
result of multiplication and addition of these hidden components. Additionally, I reported 
the results of non-parametric power spectral density analysis on noise from 
instrumentation [130]. Similar efforts to reduce chemical noise were also made by some 
manufacturers. For example, Applied Biosystems Inc. developed an algorithm based on 
the Fourier transform and notch filtering to minimize the effect of chemical impurities on 
mass spectra [174]. They tried to identify periodic patterns of chemical noise in mass 
spectra using the Fourier transform, and to reduce signal deterioration by eliminating 
these periodic patterns using a notch filter. However, their approach does not seem to be 
strictly model-based in the sense that they did not build a model for chemical noise from 
the frequency representation.  
These model-based studies represent an important advance over heuristic 
approaches. The lack of knowledge on statistical characteristics of the signal and noise in 
heuristic approaches may lead to the design of noise reduction algorithms or digital filters 
that deteriorate the true signal rather than restore it. However, more work needs to be 
done towards complete noise characterization. Prior studies may have oversimplified the 
noise sources or disregarded the importance of power spectral density analysis. For 
example, most noise analyses have not explicitly distinguished the subtypes of the high 
frequency noise; however, various electrical, physical, and chemical components of the 
mass spectrometer may generate subtypes of noise with different characteristics. 
Therefore, in order to elucidate the stochastic characteristics of noise in mass 
spectrometry, such individual noise components must be carefully separated and 
analyzed. In addition to noise subtype isolation and measurement, power spectral density 
estimation is also critical in noise characterization because this method can provide 
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guidance for digital filter design by showing the power distribution of noise over 
frequencies, which determines the magnitude and period of signal fluctuation due to 
noise in the mass spectrum.   
As part of my effort for modeling noise in MALDI TOF mass spectrometry, I 
describe a method in which I have isolated noise from instrumentation occurring in the 
MALDI TOF mass spectrometer and obtained the signal model for this type of noise 
using parametric power spectral density estimation. By "noise from instrumentation", I 
mean the interference caused by electrical sources inside or near the mass spectrometer 
including thermal noise from the transimpedance amplifier, power supply and power line 
noise, and electrical interference from the ion accelerator pulse. My results show that 
noise from instrumentation is composed of 
! 
1 f  noise and several prominent periodic 
components in addition to the common white spectrum due to thermal noise. However, it 
is encouraging that a simulation study based on the signal model of noise from 
instrumentation suggests that the errors due to only noise from instrumentation in mass 
spectra may not significantly hamper human observers or detection algorithms in finding 
meaningful patterns. The methodology could be applied to other types of noise or other 
types of mass spectrometry.  
 
3.2 NOISE MODEL FOR MALDI TOF MASS SPECTROMETRY 
I hypothesize that there exist three types of noise in MALDI TOF spectra: noise 
from instrumentation, noise from random ion motions, and chemical noise [108, 130]. 
Noise from instrumentation is generated by the random thermal motion of electrons in the 
circuits of the instrument or by electric/magnetic interference from nearby equipment. 
Noise from random ion motions originates from random ion motions and random 
fluctuations of the secondary electrons of the microchannel plate (MCP) ion detector. 
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Unlike noise from instrumentation, this type of noise is believed to be signal-dependent; 
thus, noise from random ion motions is hypothesized to be a multiplication of the signal 
intensity and a random variable. Chemical noise mainly originates from matrix clusters. 
Matrix is also ionized with the sample during the MALDI process and these matrix ions 
form clusters. The monotonically decreasing baseline is due to the presence of small 
clusters of matrix material, since the likelihood of cluster formation decreases with 
cluster size. Moreover, occasional sharp peaks in the higher mass ranges can result from 
unusually large clusters of matrix material. Among these three types of noise in MALDI 
TOF mass spectrometry, chemical noise is dominant. The proposed noise model is 
described as follows. 
 
! 
m t( ) = R t( ) " x t( ) + C t( ) + I t( )          (3.1) 
 
In Eq. 3.1, 
! 
x t( )  and 
! 
m t( ) represent the true signal and the measured signal at ion 
flying time 
! 
t , respectively. As stated in Chapter 2, since an equal sampling interval is 
required for signal processing, time was used instead of mass to charge ratio in my noise 
analysis. 
! 
R t( ) , 
! 
C t( ), and 
! 
I t( )  symbolize noise from random ion motions, chemical 
noise, and noise from instrumentation, respectively. As you can see in equation (3.1), 
chemical noise 
! 
C t( ) and noise from instrumentation 
! 
I t( )  are added to the true signal 
! 
x t( )  because these types of noise are independent from the true signal. Ion detection in 
mass spectrometry is based on counting statistics. The ion detector amplifies the number 
of ion arrivals at a given time bin utilizing the photomultiplier effect of the MCP. 
Therefore, this detection process includes two counting steps: ion arrival and 
amplification through the secondary electrons, which can be modeled using Poisson 
statistics. In Poisson statistics, the variance, which corresponds to noise power, is 
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proportional to the signal intensity 
! 
x t( ) ; thus, noise from random ion motions 
! 
R t( )  is 
described as a multiplication term to the true signal 
! 
x t( ) .  
In this dissertation, noise from instrumentation 
! 
I t( )  and chemical noise 
! 
C t( ) 
have been analyzed using signal processing techniques. The analysis of noise from 
instrumentation is introduced in the later sections of this chapter, and that of chemical 
noise in Chapter 4. 
 
3.3 FUNDAMENTAL THEORY 
In general, a random process does not show regular patterns in the time domain 
like a sine wave because many signals of different frequencies and phases are added 
together. The power spectral density of a random process provides the power distribution 
of the signal with respect to frequencies. If there is a high value at a certain frequency in 
a power spectral density, the corresponding random process has a strong sine wave with 
that frequency in the time domain [175]. The simplest way of estimating the power 
spectral density of a random process is to calculate the absolute square of the Fourier 
transform of a given realization, which is referred to as the periodogram. Power spectral 
density estimation methods based on the periodogram are called nonparametric methods 
because these methods derive a power spectral density estimate from given realizations 
without any background information on the data source. However, nonparametric 
methods suffer from poor frequency resolution and spectral leakage effects due to the 
finite length of data. The lack of resolution in nonparametric estimation becomes more 
problematic when the sampling frequency is very high but the data length is relatively 
short. In this case, a non-parametric power spectral density estimate would provide power 
information on only a relatively small number of frequencies within a wide range of 
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frequencies [175]. Spectral leakage causes ripples in a power spectral density estimate, 
which make it difficult to identify true periodic components in the signal.  
Parametric power spectral density analysis can overcome these drawbacks by 
estimating the parameters of a linear system under the assumption that the observed 
random signal is the output of the linear model when a random signal with a white 
frequency spectrum is given as input. Once a model is established, a high-resolution 
power spectral density estimate free from spectral leakage can be obtained since the 
power spectral density of the random signal is determined by the parameters of the linear 
system [175]. The differential equation between the input random signal and the observed 




x n( ) + a1x n "1( ) +L+ apx n " p( ) = w n( ) + b1w n "1( ) +L+ bq n " q( )        (3.1) 
 
In the above equation, 
! 
x n( ) denotes the observed signal system at the 
! 
n
th  time index, 
and 
! 
w n( )  the input random signal at the same time index. 
! 
H f( ) , the Fourier 
representation of the linear system, is defined as the ratio of 
! 
X f( )  and
! 
W f( ) , the 
Fourier representations of 
! 
x n( )and 
! 









,K,bq . The power spectral density of the random signal 
! 
SX f( )  is 




SX f( ) = H f( )
2




Sw f( )  is the power spectral density of the input signal with a white spectrum 
[175].  
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,K,bq = 0 , the process produced by the linear model is called an 







,K,ap = 0 , the resulting process is 
called a moving average (MA) process of order 
! 
q. Otherwise, the process is called an 
autoregressive-moving average (ARMA) process of order 
! 
p  and 
! 
q. Generally, these 
three models could be exchanged if models of infinite order be allowed. However, among 
these three types, the AR model is most commonly used for power spectral estimation 
because it can show narrow frequency components more accurately than the others with 
simple linear equations for parameter estimation [175].  
The Burg algorithm estimates the power spectral density using an AR model. The 
AR parameters are estimated by minimizing the forward and backward residuals of the 
model, which are defined as the error between the given random signal and their 
corresponding estimators at 
! 
n  and 
! 
n " p  [175]. In general, power spectral density 
estimates obtained by the Burg algorithm have high frequency resolution [175], and are 
more unbiased and stable than other power spectral density estimation algorithms using 
an AR model such as the Yule-Walker algorithm and least square estimator [107].  
Ideally, an infinite measurement of a random process is desired to develop a most 
accurate model; however, in reality, measurements have finite length due to practical 
limitations of instrumentation devices. For example, in MALDI TOF mass spectrometry, 
the maximum signal length is determined by the instrument according to a pre-defined 
limit on the maximum mass to charge ratio. In recognition of this common problem, de 
Waele and Broersen extended the Burg algorithm to obtain a more accurate model using 
multiple segments from a random process, than can be achieved using a single realization 
of the process [107]. Like the Burg algorithm, this algorithm also estimates the model 
parameters by minimizing the forward and backward residuals; however, the revised 
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algorithm attempts to minimize residuals from multiple segments simultaneously [107]. 
This extended Burg algorithm generates a more accurate model than parameter averaging 
methods, which develop a final model by averaging the parameters of the models derived 
from individual segments [107]. 
The model order must be carefully determined so that the model can represent the 
given segments well, while avoiding overfitting. In general, the residuals decrease as the 
model order increases, so the modeling process must be stopped at some point even 
though the residuals are still decreasing. In the Burg algorithm, the Akaike’s information 
criterion (AIC) is employed to select the optimum model order [107]. The AIC is 
represented as the sum of the model order and the log residual of the model with respect 
to the given random process. The parameter estimation of the Burg algorithm stops when 
the AIC is minimized. When errors between the estimated model and true random 
process is normally distributed, the AIC is defined as the following equation  
 
! 
AIC p( ) = ln RES p( )( ) +
2p
N
           (3.3)   
   
where 
! 




N  is the length of a 
given signal realization [107, 176]. In the Burg algorithm for multiple segments, the 
above definition of AIC is slightly modified so that it may reflect the fact that the 
variance of the estimated parameters becomes lower than when a single segment is used 
by a factor of 
! 




AICs p( ) = ln RES p( )( ) +
2p
NS
          (3.4) 
 
 62 
In this study, additional steps were taken to avoid overfitting. The Burg algorithm 
is prone to overfitting because it uses the same data to select the model order as are used 
to develop the model. Thus, in this study a portion of the data set was held out from the 
model development and used to select the final model. In this process, the final model 
was selected based on another metric, the Kullback-Leibler discrepancy (KLD). The 
KLD is a generalized error measure for two probabilistic distributions, 
! 
p x( )  and 
! 









           (3.5) 
 
In this case, 
! 
p x( )  represents the probabilistic distribution estimate of the model from the 
Burg algorithm, and 
! 
p x( )  the probabilistic distribution of the held-out set. In fact, the 
AIC is an estimate of the KLD that is specialized for measuring the distance between a 
set of realizations of a random process and a model developed based on them [178, 179]. 
However, in general, the AIC may not be appropriate for estimating the distance from a 
model to another independent set [179]; thus, the KLD was adopted for selecting the final 
model using the held-out set.  
 
3.4 MATERIALS AND METHODS 
MALDI TOF mass spectra were measured from a blank plate to obtain noise from 
instrumentation. This type of noise is generated by electric circuits (e.g., the 
transimpedance amplifier, power supply and power line, and the ion accelerator pulse) in 
the instrument and electric/magnetic interferences from nearby equipment. Since no 
actual ion particle detection is performed in the experiments, noise from instrumentation 
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does not include the noise caused by the ion detector. Since the gold coating of the plate 
can cause chemical noise if the laser hits it, I ensured that the laser was not directly 
illuminating the plate by installing a physical barrier between them. A total of six data 
sets were created using three MALDI TOF machines of two types to investigate how the 
power spectral density of noise from instrumentation varies with machine type, location, 
and time. Data were collected on October 7th, 2005 and October 17th, 2005 using two 
Voyager Biospectrometry instruments (Applied Biosystems, Framingham, MA) located 
in two separate proteomics core facilities of The University of Texas at Austin (UT). The 
acceleration voltage of the mass analyzer was set to 28,125 V. Each spectrum was the 
average of 256 individual scans and had 262,144 data points with a bin size of 10 ns 
(sampling rate). Each UT data set consisted of 20 mass spectra. Averaging multiple scans 
to obtain a mass spectrum has been traditionally accepted to reduce the randomness that 
may occur in data acquisition, which can be considered as an elementary noise reduction 
scheme. Therefore, I investigated the potential effects of noise from instrumentation on 
mass spectra by deriving an AR model based on the average of individual scans. It should 
be noted that the average of individual scans is still a random process, so statistics like 
the PSD can be derived from it. Data were also collected on November 4th, 2005 and 
November 21st, 2005 using a third machine, a Voyager STR MALDI TOF instrument 
(Applied Biosystems, Framingham, MA), located at the Moffitt Cancer Center (MCC). 
The acceleration voltage of the mass analyzer was set to 25,000 V. Each mass spectrum 
was the average of 250 scans and had 233,889 data points with a bin size of 10 ns. Each 
MCC data set consisted of 20 mass spectra. In each data set, 10 mass spectra were 
randomly selected and held out as a validation group to determine the optimal model 
order and the remaining 10 mass spectra were used to develop a linear model for noise 
from instrumentation. 
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The Burg algorithm for multiple segments was applied to the training portion of 
each of the six data sets to obtain an AR model for noise from instrumentation for each of 
the machines. Because the DC offset of mass spectra introduces bias in the model 
parameters, the DC offset must be estimated and subtracted [107]. In my study, the 
means of individual mass spectra were used as the estimate of the DC offset. The Burg 
algorithm for segments was implemented by de Waele and Broersen [107] using 
MATLAB® (TheMathworks, Natick, MA), and their toolbox is publicly available 
(http://www.mathworks.com). This MATLAB® implementation allows the user to limit 
the maximum model order to control the complexity of the model. The Burg algorithm 
for segments was used to develop a model on the training portion of the data. The 
algorithm uses AIC to select the optimal model order, on the training data, up to the 
specified maximum model order. The entire process was repeated several times with the 
maximal model order parameter varied from 100 to 10,000. The final model was selected 
from among this set of possible models using the validation set. The average KLD 
between each model and the held-out mass spectra was calculated and the model with the 
smallest average KLD was selected as the optimal model for the data set. 
Once the final models for the data sets were determined, the power spectral 
densities of the models were obtained using a Fourier transform from the model 
parameters. A sharp peak of the power spectral density at a certain frequency means that 
a strong sine wave with the frequency exists in the noise. However, in order to fully 
understand how noise from instrumentation affects mass spectra, a true signal without 
noise (e.g., mass spectrum free from noise) would also be needed. Since this cannot be 
obtained in general, a simulation was performed in my study in order to reveal the effect 
of noise from instrumentation on MALDI TOF mass spectra.  
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The potential effect of noise from instrumentation was investigated by adding 
simulated noise to simulated noise-free MALDI TOF mass spectra. Noise from 
instrumentation was simulated based on data generation methods proposed by Broersen 
and de Waele [180], which can generate a random process given an AR model obtained 
from the Burg algorithm. Because the noise generator produces a standard stationary 
random signal with zero-mean and unit-standard deviation, the simulated noise was 
compensated to have the mean and standard deviation estimated from real mass spectra 
of noise from instrumentation. Noise-free MALDI TOF mass spectra were simulated 
using the MALDI TOF simulation model developed by Coombes et al. [181], which I 
translated from S-PLUS® (Insightful Corp., Seatle, WA) to MATLAB®. Coombes et 
al.’s MALDI TOF model includes several key aspects of the MALDI TOF process such 
as peak broadening due to the distribution of isotopes and initial ion velocities. Generally, 
100s-1,000s molecules are ionized per laser shot with initial velocities whose mean and 
standard deviation are 350 m/s and 50 m/s respectively during the MALDI TOF process 




are ionized in each laser shot. Microchannel plate (MCP) detectors, commonly used in 
MALDI TOF, amplify the signal for detected ions by a factor of 102-104 [184]. Generally, 
TOF mass spectrometers employ the chevron MCP as a detector, which provides a gain 
of about 106-107 per ion collision [185]. Since the specifications of the transimpedance 
amplifier after the detector are not publicly available, my simulation assumes a total gain 
of 107 in ion detection and that the MCP generates no additional noise (e.g., shot noise in 
the detector). A total of 57 proteins contained in human plasma were simulated. The 
number of proteins molecules ionized by the MALDI process was calculated based on the 
relative concentration ratios of these proteins in human plasma [126]. Each simulated 
mass spectrum was assumed to be externally calibrated using six calibrants (
! 
m z  = 
 66 
175.2, 1060, 5734, 12360.5, 16951.5, 66430: arginine, bradykinin, bovine insulin, 
cytochrome C, myoglobin, bovine serum albumin) using the least square error method. 
 
3.5 EXPERIMENTAL RESULTS 
In a plot of the power spectral density, the x-axis represents the frequency (linear 
scale) and the y-axis represents the normalized power of each periodic component in 
noise (logarithmic scale). In general, a mass spectrum shows the relative abundances of 
protein/peptide species given a sample, which are actually the digitized values of the 
output voltage from the transimpedance amplifier connected to the ion detector; however, 
since the units of those values are not provided by the manufacturer, the unit of PSD 
cannot be specified in this chapter. The power spectral density was normalized with 
respect to the power gain between the input, in this case a white Gaussian random signal 
with an unit variance, and the output of the linear signal model established by the Burg 
algorithm for segments. The power spectral densities for spectra collected on the same 
machine on different days are similar (e.g., compare Figure 3.1 A and B). Thus, the 
power spectral density of noise from instrumentation remains stable over the time scale 
of this study. It was observed that the noise power at 0 Hz is non-zero and monotonically 
decreases until about 5 kHz. This power component at 0 Hz may be caused by the bias 
between the estimated DC offset of mass spectra and the true value. This bias may 
slightly affect the model parameters, resulting in the DC power component in the power 




Figure 3.1: Power spectral densities of the AR models obtained from (A) SetA_UT1, (B) 
SetB_UT1, (C) SetA_UT2, and (D) SetA_MCC. When comparing (A) and (B), the 
frequency characteristics of noise from instrumentation in the same MALDI TOF 
instrument does not vary over dates of collection. Two MALDI TOF instrument of the 
older model type (Voyager Biospectrometry) show similar power spectral densities ((B) 
and (C)) containing prominent harmonics and more periodic components. In comparison, 
the instrument of the newer model type (Voyager STR) shows no noticeable harmonics 







Nonetheless, this monotonically decreasing component may not be completely explained 
by the bias in the model parameter. One possible hypothesis is that this noise component 
may originate from 
! 
1 f  noise of the MALDI TOF instrument. This type of noise is 
mainly introduced by a fluctuation of the mobility of the free charge carriers in an 
electronic device, and it is characterized by the inverse relationship between the 
frequency and the power spectrum [186]. 
Many peaks are observed in the power spectral densities of the data from UT, 
which suggests that mass spectra from those instruments may be affected by electric or 
magnetic interferences in addition to thermal noise. Harmonics that begin at 3.125 MHz 
and continue at an interval of 6.25 MHz until 40.625 MHz are present in the power 
spectral densities of the UT instruments, which are identical models located in separate 
facilities. The fact that the harmonics are observed in both devices at UT implies that the 
source of this interference is within the mass spectrometer (compare Figure 3.1 A and C). 
On the other hand, there are non-harmonic periodic components present in the power 
spectral density for one of the UT instruments but not the other (compare Figure 3.1 A 
and C). The absence of these periodic components in the UT2 power spectral density 
suggests that external sources generating electric or magnetic interference ranging from 5 
MHz to 10 MHz may exist near the UT1 MALDI TOF instrument, but not near UT2 
since these instruments are the same machine type, but located in different facilities. In 
principle, this hypothesis could be tested by systematically turning off all other 




Figure 3.2: Normalized KLDs of the AR models with respect to the validation mass 
spectra. The KLD of each AR model is normalized with respect to its maximum and 
minimum values, and then multiplied by 100. The solid line is the KLD of SetA_UT1, 
the dashed line is that of SetA_UT2, and the dash dot line is that of SetA_MCC. The 
optimal model order of each model is decided at the point where its KLD stops 
decreasing. 
The power spectral densities of different models of MALDI TOF instruments 
were also compared (Figure 3.1). Unlike the power spectral densities of the UT 
instruments, the power spectral densities of the spectra from the MCC machine do not 
have regular patterns like harmonics. Moreover, fewer periodic components were 
observed in the MCC power spectral densities than in those of the instruments at UT 
Austin (compare Figure 3.1 A and D). The average KLD of AR models with respect to 
the validation mass spectra provides additional evidence (Figure 3.2). For SetA_UT1, the 
 70 
average KLD decreases as the model order is increased up to about 9,000 and then 
plateaus; thus, the optimal model order is the maximum order of 9,000. Similarly, the 
optimal AR model order for SetA_UT2 is approximately 8,500. However, the KLD of the 
model for SetA_MCC plateaus at about 4,500, which suggests that the power spectral 
density of SetA_MCC may contain fewer periodic components than those of SetA_UT1 
and SetA_UT2 since each term in the AR model represents a periodic component with a 
specific frequency. The power spectral density and model order optimization analyses 
imply that the newer MALDI TOF instrument (Voyager STR, Applied Biosystems, 
Framingham, MA) at MCC may employ more effective electro-magnetic shielding 
schemes than the earlier model. 
The power spectral density of noise is extremely useful when designing digital 
filters because the power spectral density indicates which periodic components are 
dominant in signal deterioration, and thus should be removed. However, it is difficult to 
determine how noise from instrumentation affects mass spectra by looking at only their 
power spectral density. Thus, the impact of noise from instrumentation was investigated 
by adding noise simulated based on the noise model to simulated noise-free MALDI TOF 
mass spectra. Figure 3.3 A presents the full view of the simulated mass spectrum without 
any types of noise that exists in MALDI TOF mass spectrometry. If the DC offsets in the 
simulated noisy spectra are ignored, there is little change in peak shapes relative to the 
simulated noise-free spectra (e.g., Figure 3.3). This is consistent with the fact that the 
average root-mean-square (RMS) magnitude of noise from instrumentation ranges only 




Figure 3.3: Simulated human plasma mass spectra. It is assumed that about 1,000 
molecules are ionized every laser illumination, and the gain of the ion detector is 107. (A) 
The entire view of the mass spectrum without noise from instrumentation. (B) The entire 
view of the mass spectrum with noise from instrumentation. (C) A zoomed view of a 
MALDI mass spectrum showing a peak near 
! 
m z  8,800. (D) A zoomed view of mass 
spectrum near 35,000 Da. In (C), and (D), the solid lines represent mass spectra with 
noise, and the dashed lines mass spectra without noise. In (D), the peak with noise from 
instrumentation is not clearly distinguished from that without noise from instrumentation. 
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Table 3.1: The average DC offset and average RMS magnitude of mass spectra in each 
data set in relative intensity. As can be seen in this table, these statistics are consistent 
over time, but vary across the instruments. The potential effect of noise from 
instrumentation was investigated by adding simulated noise to simulated noise-free 
MALDI TOF mass spectra. These DC offsets and RMS magnitudes are needed in 
generating simulation noise using the models obtained my parametric power spectral 
density analysis.    
Data Set DC offset RMS Magnitude 
SetA_UT1 255.0 6.9 
SetB_UT1 281.4 6.8 
SetA_UT2 844.5 11.9 
SetB_UT2 905.9 11.2 
SetA_MCC 1425.4 6.8 
SetB_MCC 1523.5 5.4 
 
As can be seen in Table 3.1, each of the instruments has seemingly consistent 
average DC offsets and average RMS magnitudes over time. The quality of mass spectra 
is affected by the average RMS magnitude of noise from instrumentation. That is, if the 
average RMS magnitude of noise from instrumentation of an instrument is large, mass 
spectra obtained by the instrument are significantly contaminated by noise from 
instrumentation. However, as can be seen in Table 3.1, the average RMS magnitude of 
noise from instrumentation ranges from about 6 to 12, which implies that the potential 
effect of noise from instrumentation is negligible. 
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3.6 DISCUSSIONS AND CONCLUSION 
The power spectral density reveals how the power of the periodic components 
hidden in the noise is distributed with respect to frequencies given a random process, and 
thus helps in developing filtering strategies for noise reduction. In my study, noise from 
instrumentation was separated from other types noise in MALDI TOF MS, and its power 
spectral density was estimated using the Burg algorithm for multiple segments, which 
develops an AR model for the noise by minimizing the residuals between the model and 
multiple observed noise segments simultaneously. The Burg method for segments 
provides much less biased models than other methods such as parameter averaging 
methods when multiple signal segments from the same source are available for parameter 
estimation [107]. Thus, this algorithm is well suited for the purpose of estimating the 
power spectral density of a random process with a finite length, but with multiple 
realizations available, such as is the case for noise from instrumentation. To see the 
variation of the power spectral density with the instrument type, location, and date of 
collection, six data sets of noise from instrumentation were measured from three different 
MALDI TOF instruments. The power spectral density does not vary much over the time 
scale studied, but it varies with the instrument type and location. The comparison of the 
power spectral densities from two identical instruments located in the different facilities 
suggests that both internal and external electric or magnetic interference sources affect 
the mass spectra. Therefore, shielding should be carefully considered to avoid signal 
deterioration due to the interference from nearby equipment. Interestingly, in the 
comparison between the newer and older models, fewer periodic components are seen in 
the power spectral densities of the newer instrument than in those of the older ones. This 
is probably a consequence of more advanced instrumentation design of the newer model 
that provides better shielding to the internal or external interference. 
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The potential effect of noise from instrumentation was investigated through a 
simulation study. The simulation suggests that noise from instrumentation may not 
significantly impact the interpretation of mass spectra. In fact, the RMS magnitude of 
noise is almost negligible in the high mass region when it compared to the randomness of 
the peak shapes due to ions’ random initial velocities.  
In conclusion, this chapter presents a systemic methodology for modeling noise 
from instrumentation in MALDI TOF MS on the basis of parametric power spectral 
density estimation using multiple realizations. My study opens a way of isolating a noise 
component, and measuring its stochastic features, which are critical in designing filters 
for signal manipulation often needed for MS applications like biomarker identification. In 
addition, this methodology will also benefit system designers of mass spectrometers as 
well by providing reliable spectral information on noise, letting them developing better 
shielding strategies for potential signal interference. For example, in my study, the power 
spectral densities of the mass spectrometers of the earlier model indicate that more 
shielding should be considered to avoid the periodic interference for a higher signal 
quality although the overall impact of noise from instrumentation was assessed to be low 
according to my simulation study. Isolating individual subtypes of noise and performing 
stochastic modeling of them will provide an important perspective on how to suppress 
signal deterioration due to the noise effectively by showing the power distribution over 
frequencies. Furthermore, such noise analysis can also be extended to other types of 
instrumentation like ESI MS once the types of noise in the instrumentation are identified 
and isolated. Hence, this technique is expected to benefit noise reduction studies for other 
types of MS instrumentation as well.  
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Chapter 4: ANALYSIS OF CHEMICAL NOISE IN MALDI TOF 
MASS SPECTROMETRY 
4.1 INTRODUCTION 
In the literature of mass spectrometry, “chemical noise” refers to many types of 
interferences due to chemical impurities in the sample. This definition covers a very wide 
range of sources of potential interferences in mass spectrometry, which sometimes leads 
to misunderstanding and confusion. Moreover, since chemical impurities in the sample 
depend on the type of mass spectrometry (e.g., MALDI TOF or ESI) and analytes, the 
patterns of chemical noise are highly variable. Thus, it is necessary to first define 
chemical noise of MALDI TOF more precisely in the context of my noise analysis study. 
In my study, chemical noise is defined as the unwanted interferences due to 
matrix in mass spectra. Matrix is organic material with a small molecular weight. In 
MALDI mass spectrometry, sinapinic acid or 
! 
" -cyano-4-hydroxycinnamic acid is often 
used. It is mixed in large molar excess compared to the proteins and peptides. The 
primary role of the matrix material is to absorb the laser energy and transfer it to the 
sample, helping the molecules to be ionized without damage due to high laser power. The 
matrix is also used to physically separate the various components of the sample, 
preventing aggregation or precipitation [114]. However, the interaction of matrix material 
with itself, i.e., clustering, introduces noise into the measured signal. This noise from 
chemical impurities mainly manifests as a monotonically decreasing baseline and a high 
signal variance in the low mass to charge ratio region. 
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Figure 4.1: An example MALDI TOF mass spectrum of typical calibration proteins: 
insulin, thioredoxin, and myoblobin. The low mass region is significantly affected by 
chemical noise. 
Figure 4.1 shows an example MALDI TOF mass spectrum of typical calibration 
proteins: insulin (5,808 Da), thioredoxin (12,000 Da), and myoglobin (16,952 Da). The 
second peak represents doubly charged molecules of myoblogin (≈ 8,000). As can be 
seen in Figure 4.1, a monotonically decreasing baseline due to matrix material extends up 
to nearly 60,000 Da, and the low mass region is corrupted by noise with high variance. It 
is observed that the variance of the noise also decreases with the baseline. 
Many methods for reducing chemical noise in mass spectra have been developed 
and tested. Prior studies of noise reduction for mass spectrometry were extensively 
reviewed in Chapter 2 (Preprocessing) and Chapter 3 (Introduction). Since every method 







better than the others. As discussed in Chapter 3, the current approaches to chemical 
noise reduction in mass spectrometry can be summarized in two categories: heuristic 
methods and model-based methods. Heuristic approaches attempt to remove the baseline 
or high-frequency noise using algorithms whose parameters are determined in an ad hoc 
manner while model-based approaches build a mathematical model and perform noise 
reduction based on the model.  
However, conventional noise reduction schemes are not effective for denoising 
chemical noise because the characteristics of chemical noise are different from those 
assumed in the model (e.g., Gaussian white noise). Because chemical noise originates 
from real chemical impurities, its characteristics are very similar to those of the mass 
spectrometry signal from the analyte, which makes it difficult to distinguish chemical 
noise from the real signal. Moreover, chemical noise is non-white and non-stationary. 
From a signal processing point of view, chemical noise is a mixture of frequency 
components of different powers and the power of each frequency component varies over 
time. Thus, conventional noise reduction schemes based on Fourier analysis fail to 
eliminate chemical noise.  
The wavelet transform (WT) is a signal analysis method that decomposes a given 
1D or 2D signal into frequency sub-bands over time. While the Fourier transform only 
shows the frequency distribution of a given signal, the WT describes the change of the 
distribution over time. This is why the WT is used for analysis of non-stationary signals.  
Denoising via the WT is mostly done by thresholding. After decomposing the 
given signal using the WT, a threshold is set for each of the frequency sub-bands and the 
wavelet coefficients below the threshold are removed. Then the denoised signal is 
reconstructed by the inverse wavelet transform (IWT) of the shrunk wavelet coefficients 
[187, 188]. One of the benefits of wavelet denoising is that it can selectively reduce high 
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frequency noise while preserving the high frequency structure of the signal because the 
WT can provide the time location as well as the magnitude of a certain frequency 
component. In contrast, noise reduction through Fourier analysis simply rejects high-
frequency components above a cut-off frequency, resulting in the loss of high frequency 
components of the signal [134].  
There have been several studies of application of the WT to noise reduction in 
mass spectrometry [54, 77, 135, 170, 189]. Barclay and Bonner extensively studied the 
efficacy of the discrete WT (DWT) as a denoising method for mass spectrometry as 
compared to digital filtering (Fourier transform) and a heuristic smoothing algorithm 
(Savitzky-Golay) [135]. They applied these three methods to synthetic Gaussian and 
triangular mass spectra and real experimental ESI mass spectra. Barclay and Bonner 
observed that denoising using the DWT effectively removes the high frequency noise but 
keeps the narrow peak shapes while digital filtering based on the Fourier transform lost 
most of the narrow peaks [135]. Their study shows that the WT does not blindly smear 
out all the high frequency components above a certain cut-off frequency, but instead it 
successfully discerns the signal and noise that have similar frequencies. Qu et al. also 
applied the DWT to analyzing SELDI TOF mass spectra of prostate cancer serum 
samples [54]. They attempted to compress the mass spectra by removing the noise 
components through thresholding and then reconstructing the thresholded wavelet 
coefficients. They concluded that data compression based on the DWT can retain patterns 
useful for disease detection [54]. Denoising through the DWT can be done very quickly 
through the fast wavelet transform algorithm [190]. However, since the wavelet 
coefficients obtained by the DWT are not shift-invariant, the denoised signal may suffer 
from some artifacts near discontinuities (pseudo-Gibson phenomenon) [191]. Another 
problem is that the denoising results highly depend on the shift of the input signal [170]. 
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To resolve these issues, Coombes et al. adopted the discrete stationary wavelet transform 
(SWT) to denoise SELDI TOF mass spectra [170]. The SWT is often referred to as the 
undecimated discrete wavelet transform (UDWT) in the literature. This variant of the WT 
algorithm produces shift-invariant wavelet coefficients of a given signal by averaging the 
wavelet coefficients of the ε-shifted copies of the input signal [191]. In their study, 
Coombes and his colleagues applied various levels of thresholds to the wavelet 
coefficients to find an optimal threshold that efficiently performs denoising but preserves 
the peaks in the mass spectra [170]. They reported that they identified more peaks of high 
quality from the denoised mass spectra than the raw mass spectra [170].  
However, current noise reduction methods using variants of the WT attempt to 
simultaneously estimate and reduce noise on the basis of a single mass spectrum, which 
is an ill-posed problem [192]. This problem occurs when two unknown variables (noise 
and signal) are to be estimated from a single equation (the noisy signal). Thus, previous 
methods set criteria for quality assurance (e.g., smoothness measurement) or made 
assumptions on the statistical properties of the signal or noise (e.g., white Gaussian noise) 
[192]. Moreover, the non-white and non-stationary characteristics of chemical noise have 
not been considered in determining a universal threshold for all the decomposition levels. 
Thus, it is critical to investigate the characteristics of chemical noise in the wavelet 
domain and to design a denoising method based on this prior knowledge. 
In this chapter, I propose a new thresholding method, adaptive thresholding using 
multiple realizations (ATMR). I investigated the time-frequency patterns of chemical 
noise in the wavelet domain with multiple realizations of a mixture of matrix (sinapinic 
acid) and several reference proteins. Using the patterns of chemical noise in the wavelet 
domain, I obtain the adaptive thresholds for each of the decomposition levels, which 
takes into account the non-white and non-stationary nature of chemical noise. The 
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threshold is extensively tested on another set of MALDI TOF mass spectra of different 
reference proteins to evaluate the denoising results. In addition to high-frequency noise 
reduction, I present a novel baseline correction algorithm, called the wavelet baseline 
correction (WBC) algorithm, which can eliminate the monotonically decreasing baseline 
in the highest level approximation of wavelet decomposition 
 
4.2 BACKGROUND  
In this section, I review fundamental theories for analysis of chemical noise using 
the WT. First, I introduce multiresolution analysis in signal processing. Multiresolution 
analysis enables decomposition of a complex function into multiple simpler forms using 
several resolutions so that they can be analyzed separately. The WT makes it possible to 
do multiresolution analysis by projecting a given signal onto multiple basis functions 
with frequency increasing by the power of 2. I give a brief mathematical review on the 
WT. In addition, I will introduce the SWT in more depth because my chemical noise 
analysis is based on the SWT. Finally, I review threshold estimation methods and 
thresholding methods in the wavelet domain that have been commonly performed in 
wavelet denoising.  
 
4.2.1 Multiresolutional analysis and the wavelet transform 
Unlike noise from instrumentation, chemical noise is non-stationary. In a 
stationary random process (e.g., noise from instrumentation), at least its first order 
statistics (e.g., mean) and second order statistics (e.g., variance) are time-invariant. Based 
on this important property, autocorrelation and power spectral density can be obtained, 
which provides useful information for filter design. However, the statistical 
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characteristics of chemical noise are not stationary since matrix clusters, which are the 
primary source of the noise, are more likely to be formed in the low mass region than in 
the high mass region. For example, the mean of chemical noise over time is 
monotonically decreasing, which is time varying (Figure 4.1). Ordinary Fourier 
transform-based approaches are not suitable for non-stationary signal analysis because 
they can reveal only the power distribution over frequencies, but cannot describe how the 
power distribution changes with respect to time. Therefore, a more advanced signal 
processing technique than Fourier transform based methods for stationary random 
processes must be applied for spectral analysis of chemical noise. 
Traditionally, non-stationary signals have been modeled and analyzed using the 
short-time Fourier transform (STFT). The STFT can show how frequency components 
vary over time by taking a Fourier transform of a windowed segment of a given signal 
and by moving the window over the time axis, resulting in a two dimensional 
representation of the signal (time vs. frequency). The STFT is mathematically 




STFT t ', f( ) = x t( ) "W t # t '( )[ ]
t
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In Eq. 4.1, a moving window 
! 
W t " t'( )  is multiplied by the input signal 
! 
x t( )  and a 
Fourier transform is performed at each translation 't  of the window function. As a 
result, the frequency representation of 
! 
x t( )  at 't  is obtained. The energy distribution of 
the non-stationary signal over the time and frequency is called a “spectrogram,” which 
corresponds to a power spectral density in spectral analysis of a stationary random signal.  
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While it is true that the STFT is very useful in analyzing non-stationary signals, 
deciding an optimal window size still remains an open problem of deciding an optimal 
window size. This problem is often referred to as the uncertainty principle of time and 
frequency [193], which says that there must exist a trade-off between the frequency 
resolution and the time resolution. Specifically, if the window size becomes larger, then 
the frequency resolution increases, but the time resolution decreases, and vice versa.  
Multiresolution analysis (MRA) can alleviate this limit of the STFT without 
violating the uncertainty principle. Intuitively, for analyzing signal components with low 
frequencies, a larger window is used, and for analyzing signal components with high 
frequencies, a window with a smaller scale is employed. Thus, it enables analysis of a 
given signal at different frequency sub-bands with different resolutions. In particular, the 
WT performs MRA by dividing the time-frequency plane into dyadic tiles. 
The wavelet transform enables a multi-resolution analysis. The wavelet transform 
provides good frequency resolution for low frequency signals and good time resolution 
for high frequency signals. This property of the wavelet transform is especially useful in 
analyzing high frequency components for short durations and low frequency components 
for long durations. In practical applications, the discrete wavelet transform is performed 
by using a filter bank. Using the filter bank, the given signal is decomposed into 
orthogonal sub-bands, each of which represents a specific frequency range over time. 
Mathematically, this signal decomposition using the discrete wavelet transform is 
described as  
 








2$           (4.2) 
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where !  denotes the basis (scaling function), 
! 
k  is the amount of shift in the time 
domain, and j  is the level of decomposition. Just as the Fourier transform represents a 
signal as a set of coefficients indicating the amount of each basis function (sinusoid) it 
contains, the wavelet transform represents a signal as a set of coefficients ( kja , ) 
indicating how similar the signal is to the wavelet basis function at each scale. Under the 
assumption of orthogonality of a basis, the wavelet coefficients are derived by the 
function inner product as follows. 
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From a multiresolution analysis point of view, a signal can be represented by the sub-
spaces spanned by the orthogonal bases (scaling and wavelet functions). Suppose that a 




R( ), where every function 
! 
f t( ) has a well defined integral 
of the modulus of the function on the real line [194]. I define a sub-space 
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In Eq. 4.3, 
! 
Z  denotes the entire integer set. When I decrease the scale, I can increase the 
size of the subspace as follows.  
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Intuitively, when the time is multiplied by a power of 2, the resolution of the scaling 
function also increases by the power (if the power is less than 1, the resolution 
decreases). Thus, the sub-space spanned by the high-resolution scaling function can 
include more functions in ( )RL2 ; the size of the sub-space increases as well. 
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However, instead of continually increasing the resolution of the scaling function to 
represent a given function 
! 
f t( ), a set of functions that are orthogonal to the scaling 
functions are used to describe the complement of jV . These functions are called as 
wavelet functions and are denoted by ! . Suppose that the sub-space spanned by 
! 
2
j / 2" 2 j # k( )  is jW . Then, jW  is the orthogonal complement of jV  and it fills the 
difference between jV  and 1+jV  [194].  
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Eq. 4.6 can be recursively applied to derive a general representation of ( )RL2  based on 
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 is usually set to 0, but it can be set to any arbitrary integer. 
! 
c j k( )  and 
! 
d j k( )  (Eq. 4.9) are referred to as approximation and detail coefficients, respectively. 
From Eq. 4.7 and 4.8, I know that the approximation coefficients 
! 
c j k( )  correspond to 
jV  and the detail 
! 
d j k( )  to jW . Signal modification based on the DWT, such as 
denoising, is performed by manipulating the approximation or detail coefficients. The 
signal can be reconstructed from its wavelet coefficients. For example, in denoising using 
the DWT, reconstructing a measured signal after suitable modification of its wavelet 
coefficients can produce a version of the signal in which noise is suppressed and the true 
signal is enhanced. I refer the reader interested in the mathematical details of the WT to 
books and articles of this topic [190, 194, 195]. In general, the DWT is implemented 
using recursive low-pass and high-pass filtering followed by decimation (filter bank), and 
the time complexity of this filter-based algorithm is linear ( )(NO ) [194]. 
The discrete stationary wavelet transform (SWT) is often referred to as the 
undecimated discrete wavelet transform (UDWT). The DWT is a very powerful method 
for analyzing many types of stationary or non-stationary signals; however, since the 
DWT is not shift-invariant, a shift of the input signal in the time domain does not lead to 
a shift of the wavelet coefficients of the signal, resulting in inconsistent denoising 
performance for a shifted version of the input signal [191, 194, 196, 197]. This shift-
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invariance problem can be overcome through the 
! 
" -decimated discrete wavelet 
transform. 
Basically, the decimation step following the convolution of the DWT causes the 
DWT not to be shift-invariant [191, 197]. In a decimation, even or odd indexed elements 
of the input signal are chosen, resulting in potential bias in characterizing the signal in the 
wavelet domain. Pseudo-Gibbs phenomena exhibited around discontinuities after wavelet 
denoising are a good example of this [191]. In the 
! 
"-decimated DWT, all the possible 
choices of indices for decimation at every level of decomposition are taken into account. 
For a given maximum decomposition level 
! 
J , ε is defined as a binary array as 
  
! 
" = "1 "2  K"J[ ], where ( )Jjj !!1 "  can have 0 or 1 and these binary numbers denote 
the choice of even or odd indices for decimation, respectively. Because the ε-decimated 
DWT performs the DWT considering every ε combination at every level of 
decomposition, the length of the wavelet coefficients does not decrease with 
decomposition. There are slightly different ways of performing the ε-decimated DWT. 
The simplest way is to directly run multiple DWTs; however, this direct method is 
extremely inefficient. The SWT can do this task in 
! 
O n log n( )( )  time through a simple 
undecimated filtering [191, 197].  
Conventional denoising strategies, thresholding, for the DWT are also applicable 
to denoising using the SWT. Actually, denoising using the SWT is known to be more 
robust and reliable than denoising using the ordinary DWT [198] since the final 
reconstructed signal from the wavelet coefficients is obtained by averaging the inverse 
transform of the ε-decimated (redundant) wavelet coefficients. Moreover, the shift 
invariance of the SWT makes it possible to estimate local thresholds for a given non-




4.2.2 Denoising by thresholding 
The main idea underlying wavelet-based de-noising methods is that the wavelet 
representation can separate the signal and the noise by distributing the energy of the noise 
over a large number of wavelet coefficients having small amplitudes and simultaneously 
distributing the energy of the signal over a small number of coefficients having larger 
amplitudes. Thus, the signal can be de-noised by applying a threshold to remove small 
wavelet coefficients in appropriate sub-bands.  
The two most common types of thresholding operations are hard thresholding 
(Eq.4.10) and soft thresholding (Eq. 4.11) [193, 199].  
 
! 
yhard t( ) =
x t( ),       x t( )  > "
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! 
ysoft t( ) =
sgn x t( )( ) " x t( )( ),       x t( )  > #





       (4.11) 
 
In Eq. 4.10 and 4.11, 
! 
x t( )  is the original wavelet coefficients of a given level of 
decomposition and !  denotes a threshold. 
! 
yhard t( )  and 
! 
ysoft t( )  are the denoised 
wavelet coefficients by hard thresholding and soft thresholding, respectively. In general, 
it is known that hard thresholding keeps the edge information, but causes some artifacts 
while soft thresholding provides smoother denoising results than hard thresholding.  
The selection of the threshold parameter !  is critical. If !  is too small as 
compared to the variance of noise, the residuals of denoising cause artifacts in the 
reconstructed signal. If !  is too large, important information in the signal is modified or 
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deleted. Many methods such as the universal threshold estimate, VisuShrink [188], and 
SureShrink [187] have been proposed to estimate the threshold parameter from an 
estimate of the noise variance.  
VisuShrink is a thresholding method that has been most widely used for denoising 
[188]. The threshold in VisuShrink is defined as: 
 
)log(2 N!" =           (4.12) 
 
where ! is an estimate of noise variance and N  is the length of the signal. The 












 is a Gaussian stochastic process with zero mean and variance 
! 
" 2. The probability that 




 is smaller than )log(2 N!  converges to 1 as N  goes to 
infinity [200]. In general, !  is not known; however, it can be estimated using the robust 
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        (4.14) 





, some outliers can be effectively rejected from the estimate of ! .  
VisuShrink sometimes overestimates the threshold; it may remove signal 
components with low strength as well as noise. To alleviate this problem, Donoho and 
Johnstone designed SureShrink, which adaptively estimates a threshold level by 
minimizing the Stein unbiased estimate of risk (SURE) [187, 200]. This algorithm selects 
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the optimal threshold 
! 
"  from 
! 
0, " 2logN ][  that gives the minimum value of the 
mean-squared soft-thresholding error [187, 200].  





R( ) in estimating a function 
! 
f t( ) [188, 200]. Unlike VisuShrink, there is no 
closed-form solution for estimating the minimax threshold and the threshold is 
numerically solved. However, the minimax threshold asymptotically converges to the 
VisuShrink threshold )log(2 N!  [188, 200]. 
Direct application of the thresholding methods described above for reducing 
chemical noise is not reasonable because the methods were designed under the 
assumption that the noise is additive, Gaussian, and white. However, chemical noise 
cannot be modeled as sich; hence, I attempted to estimate a threshold that can describe 




Figure 4.2: Mass spectra of matrix material alone and matrix plus several reference 
proteins (gray and black, respectively). B is a zoomed view of the low mass region of A. 




Table 4.1: The sets of mass spectra used for the analysis of chemical noise. TR denotes 
training set and TS denotes test set. The thresholds obtained from TR sets were tested on 
their corresponding TS sets. 


























4.3 MATERIALS AND METHODS  
4.3.1 Data sets 
A series of controlled experiments were performed in order to statistically 
characterize the noise from chemical impurities. However, the noise from chemical 
impurities cannot be completely isolated since spectra from any experiment exhibit noise 
due to instrumentation. However, since noise from instrumentation does not significantly 
affect the quality of a mass spectrum (Chapter 3), measurements of the chemical noise 
component are made in the presence of noise from instrumentation. Moreover, noise from 
random ion motions also exists because real materials (i.e., matrix material and reference 
proteins) were used for the measurements. In fact, I observed that noise in the high mass 
region looks like noise from instrumentation; thus, my wavelet denoising also removes 
noise from instrumentation. 
Since the largest component of the chemical noise arises from protonated clusters 
of matrix material, it might seem that the ideal experiment would be to collect mass 
spectra of matrix material alone. In practice, however, matrix material alone does not 
behave the same way as matrix material in the presence of protein (Figure 4.2). Figure 
4.2 A shows an example mass spectrum of matrix material alone and B an example mass 
spectrum of matrix material plus several reference proteins. These two mass spectra were 
measured with the same instrumentation parameters. However, as shown in Figure 4.2, 
even by visual inspection, it is apparent that the noise properties (e.g., noise variance and 
baseline) are different. Thus, I used only the mass spectra of matrix material plus several 
reference proteins to characterize chemical noise. 
Table 4.1 summarizes the sets of MALDI TOF mass spectra that were used for 
the analysis of chemical noise. The data were acquired using a Voyager STR MALDI 
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TOF instrument (Applied Biosystems, Framingham, MA, USA), located at the Moffitt 
Cancer Center (MCC). The matrix consisted of a 28 mg/ml solution of sinapinic acid 
(Sigma-Aldrich, St. Louis, MO, USA) in 50% acetonitrile. The matrix was mixed 1:1 
with the reference proteins in 1% acetonitrile and 0.1% formic acid. The choice of 
reference proteins was made based on three factors: (a) mass in the range of interest for 
protein profiling, (b) stable in solution, and (c) commercially available. In this study, 
insulin (5,080 Da), thioredoxin (12,000 Da), myoglobin (16,952 Da), ovalbumin (42,000 
Da), lysozyme C (14,000 Da), insulin B chain (3,500 Da), beta casein (24,000 Da), 
ribonuclease B (14,700 Da), and cytochrome C (12,300 Da) were used as reference 
proteins (Table 4.1). The training sets (TR 1 and TR 2 in Table 5.1) were made from 
insulin, thioredoxin, and myoblobin, and the test sets (TS 1-1, TS 1-2 and TS 2) were 
created from combinations of the other proteins (Table 4.1). For TR 1, TS 1-1, and TS 1-
2, the accelerating voltage was 25,000 V with 94% of grid voltage. The delay time was 
set to 400 ns and the bin size was 4 ns. For TR 2 and TS 2, some of the instrumentation 
parameters were slight changed by the operator several measurements to increase the 
qualitity of the mass spectra; 93.5% of the grid voltage and 600 ns of delay time were 
selected. It is common for the operator to tune the instrumentation parameters to have 
clear peak shapes. The laser intensity was varied between 2,300 and 2,600 to yield mass 
spectra of high quality. Although I could not find significant visual differences between 
these two groups of sets of mass spectra (i.e., TR 1, TS 1-1, and TS 1-2 vs. TR2 and 
TS2), I performed separate experiments to prevent some unknown non-homogeneity 
between the two groups from interfering in my analysis.  
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4.3.2 Denoising using multiple mass spectra of chemical noise 
 The MATLAB® 7 Wavelet Toolbox was used to develop the adaptive 
thresholding using multiple realizations (ATMR) and wavelet baseline correction (WBC) 
algorithms. In the ATMR, the mass spectra in the training set (e.g., TR 1 or TR 2) were 
decomposed by the SWT into approximations and details. In general, the choice of a 
suitable level of decomposition and wavelet basis depends on the signal and experience.  
The level of decomposition was empirically determined to be eight (i.e., 8=J ) 
so that the highest level approximation could clearly demonstrate the monotonically 
decreasing baseline. As a wavelet basis, the Haar wavelet (Figure 4.3) was employed in 
this study because the use of this wavelet function clearly reveals the shape of the 




Figure 4.3: The Haar scaling )(!  and wavelet )(!  functions (A and B respectively). 
These two functions are used to obtain the approximations and details of the wavelet 
decomposition respectively.  
 
High frequency noise reduction and baseline elimination were performed using 
the details and approximations of the decomposed mass spectra respectively. In high 
frequency noise analysis, the noise variance of each detail is estimated for determining a 
threshold. Because the noise variance of chemical noise varies over time (i.e., non-
stationary), the details were evenly divided with an interval of 512 time points and then 
the noise variance of each interval was estimated using Eq. 4.14. The length of the 
interval was empirically selected such that the wavelet coefficients within the interval 
seem to be stationary. The threshold for each interval was calculated using Eq. 4.12, 
where the !  is the estimate of the noise variance of each interval and N  is set to the 
length of the detail. 
The median among the thresholds obtained from multiple realizations was 
selected as a robust threshold. For example, if there are 10 mass spectra of chemical noise 
in the training set, every interval will have 10 threshold estimates obtained from the 10 
A B 
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mass spectra. Then, the median in magnitude among those thresholds estimates is 
selected as the threshold for the interval.  
As can be seen in Figure 4.4 A, the thresholds were over-estimated where the 
reference proteins were located. Moreover, the thresholds might reflect subtle changes in 
the noise variance. Therefore, a robust non-linear regression method was employed to 
reject the effect of the reference proteins and to smooth the thresholds. After testing a 
variety of regression functions such as linear and high-order polynomial functions, a two-
term exponential function, dxbx ceae + , was selected to model the pattern of the threshold 
of the exponential decrease in the low mass region and the plateaus in the high mass 
region (Figure 4.4 B). The use of a robust regression method makes it possible to reject 
the overestimated thresholds due to the reference proteins. The main disadvantage of 
least square regression is that the regression result is highly affected by outliers because 
outliers produce large squared errors and these large squared errors make the outliers 
more influential in the regression process than is appropriate. Robust regression with 
bisquare weights alleviates the influence of outliers by iteratively assigning small weights 
to the outliers during the regression process [201]. This algorithm calculates the weights 
for the outliers as the ratios of their residuals and the median absolute deviation of the 
residuals. The sample points with ratios larger than 1 are considered to be outliers and are 
ignored [201].  
Finally, the threshold was zero-order interpolated over the entire region. The mass 
spectra in the test set (e.g., TS 1-1, TS 1-2, or TS 2) were decomposed into the same 
number of levels and with the same wavelet. Then the decomposed details of the mass 
spectra were denoised with the threshold obtained from the training data set. In this study, 
soft thresholding was used because soft thresholding produces smoother curve shapes 




Figure 4.4: The 1 level detail of an example mass spectrum in TR 1 and its threshold 
estimates (dashed lines). The detail was divided into small intervals of 512 time ticks and 
a local threshold was estimated within each interval (A). Because of the reference 
proteins, the local thresholds were over-estimated in some regions. Robust non-linear 
regression analysis was performed using a two term exponential function, dxbx ceae + , in 
order to obtain a smooth threshold (B).  
 
  
Figure 4.5: The 8 level approximation of an example mass spectrum in TS 1-1 and its 
baseline estimates (tick solid lines). The approximation was divided into small intervals 
of 100 time ticks and a crude baseline estimate was estimated with local minima of the 
intervals (A). Because of the reference proteins, the baseline was over-estimated in some 
regions. Robust non-linear regression analysis was performed using a two term 
exponential function, dxbx ceae + , in order to reject the over-expressed values and 




The baseline was eliminated at the highest level approximation (Figure 4.5) using 
the WBC algorithm. The baseline is clearly seen in the approximation without high-
frequency components, which makes it easier to estimate the baseline in the wavelet 
domain than in the original signal. Unlike threshold estimation in high-frequency noise 
reduction, baseline estimation was performed on individual mass spectra since the 
baseline depends on the particular proteins contained in the sample.  
In order to estimate the baseline, the entire mass (time) range was evenly divided 
into intervals, whose width was empirically set to 100. A more narrow width enables to 
obtain a finer baseline estimate. The lowest value of each interval was selected as a 
representative point and then the robust non-linear regression of a two-term exponential 
function was applied to the representative points in order to obtain a smooth baseline. 
This baseline estimate was also zero-order to the entire mass (time) range. After 
estimating the baseline, the highest level approximation was corrected with the baseline 
in a similar way to soft thresholding. That is, the points larger than the baseline estimate 
are shrunk by the height of the baseline and those smaller than the baseline estimate are 
reduced to zero. 
The denoised details and the baseline-corrected approximation were reconstructed 
using the inverse discrete stationary wavelet transform (ISWT). The denoised mass 
spectra were evaluated in terms of visual inspection, the number of peaks, and the S/N of 
the detected peaks. In order to identify peaks from mass spectra, I employed the peak 
detection algorithm developed by Coombes et al [103]. 
The ATMR and WBC algorithms were extensively compared with conventional 
thresholding and baseline elimination methods such as VisuShrink. The baseline 
correction and denoising results of these two methods were qualitatively compared 
through visual inspection. In addition, the denoising results were quantitatively evaluated 
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in terms of the number of detected peaks and the S/Ns of the detected peaks. For this 
purpose, the simultaneous peak detection and baseline correction (SPDBC) algorithm 
developed by Coombes et al. [103] was used. The SPDBC algorithm operates in the time 
domain (
! 
m z  domain). This algorithm was also employed to eliminate the baseline of 
the mass spectra denoised using VisuShrink because VisuShrink only reduces the high 
frequency. The parameters of the SPDBC algorithm are determined by the resolution 
(
! 
m "m ) of the MALDI TOF mass spectrometer. According to the product manual, the 
resolution of the Voyager STR MALDI TOF instrument (Applied Biosystems, 
Framingham, MA, USA) can be larger than 1,000 for myoglobin (16,952 Da) in the 
linear mode. In this study, I assumed that the resolution is about 200 in order to avoid 
selecting small variations due to noise.  
  
4.4 EXPERIMENTAL RESULTS 
4.4.1 Chemical noise characterization using the SWT 
Figure 4.6 shows example mass spectra of the training (TR 1, blue) and test data 
(TS 1-2, red) respectively. As can be see in Figure 4.6, the noise variance of the two mass 
spectra in the low mass region look similar, but their baseline shape are different around 
the peaks of the reference proteins. This observation supports my approach to denoising 
chemical noise in which the high frequency noise is reduced based on a threshold 
estimated from the multiple realizations, but the baseline is individually corrected. 
Similar observations were also made about other training and test sets. 
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Figure 4.6: Example mass spectra of TR 1 and TS 1-2 (black and gray, respectively) (A) 
and their zoomed views of the low mass region (B). Overall, chemical noise is similarly 






Figure 4.7: The 8 level approximation 
8
c  and 1 level detail 
1
d  of a mass spectra 
decomposed using the SWT (A and B respectively). 
8
c  shows the basic shapes of the 
peaks of the reference proteins and the monotonically decreasing baseline and 
1
d  







d  and 
8
d  of an example mass spectrum. The noise level of 
1
d  is marked 
as dashed lines. In the low mass region, the amplitude of 
8
d  is much larger than that of 
1
d  (A), while they do not look different in the high mass region (B). The sudden large 






Figure 4.9: The histograms of the level 1 detail in the low mass region ( zm /  < 20,000) 
and high mass region ( zm /  > 20,000). The distribution of the high mass region could be 
modeled as a Gaussian distribution (dashed line in B). The distributions of low mass 




The mass spectra were decomposed to 8 levels (i.e., 
! 
J = 8) using the Haar 








 of an 
example mass spectrum (A and B respectively). As can be seen in Figure 4.7 A, the 
approximation shows the basic shapes of the peaks of the reference proteins and the 
monotonically decreasing baseline, which makes it possible to eliminate the baseline in 
the wavelet domain. The variance of the detail (Figure 4.7 B) also shows a monotonically 
decreasing shape over time. The large variations in the middle were caused by the 
reference proteins (Figure 4.7 B). Interestingly, this observation seems to support the 
noise model proposed in Chapter 3. According to the noise model (Eq. 3.1), the noise 
strength would increase with the heights of peaks because of the multiplicative noise 
component 
! 
R t( ) . Thus, the large variations over the chemical noise strength in the 1 
level detail 
1
d  seem to account for the multiplicative noise in mass spectrometry. 
However, further studies need to be done to obtain the statistical characteristics of noise 
from random ion motion 
! 
R t( ) . 
The 1 and 8 level details, 
1
d  and 
8
d , were studied to see if chemical noise could 
be modeled as white noise. Figure 4.8 compares 
1
d  and 
8
d  (dashed line and solid line) 
in a zoomed view. As can be seen in Figure 4.8, the amplitude of chemical noise in the 
low mass region ( zm /  < 20,000) increases along with the decomposition level. For 
instance, while the maximum deviation of 
1
d  is about 100, that of 
8
d  almost reaches 
up to 600 (Figure 4.9 A). In Figure 4.8, the x axis and y axis represent the time tick and 
the amplitude of the wavelet coefficients. The wavelet coefficients with large amplitudes 
in the middle of the x axis were formed by the reference proteins. It was observed that the 
amplitudes of the wavelet coefficients corresponding to the signals of the reference 
proteins and chemical noise grow together as the level increased. This observation shows 
that chemical noise is non-white and, in the wavelet domain, it behaves similarly to the 
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signals of the reference proteins. This is mainly because chemical noise originates from 
small organic molecules. In contrast, the noise level in the high mass region ( zm /  > 
20,000) does not vary much across the levels (Figure 4.8 B), which shows that this noise 
can be modeled as white noise.  
The distributions of chemical noise were also investigated. Figure 4.9 shows the 
distributions of the wavelet coefficients of the 1 level detail in the low mass and high 
mass regions (Figure 4.9 A and B respectively). As can be seen in Figure 4.9, the 
distribution of the high mass region could be modeled as a Gaussian distribution (the 
dashed line in Figure 4.9 B); however, the distribution of the low mass region does not 
appear to be Gaussian. This analysis confirms that noise in the high mass region is mainly 






Figure 4.10: An example raw mass spectrum of TS 1-2 and the mass spectra denoised by 
VisuShrink and ATMR (A, B and C respectively). The images in the second column are 





Table 4.2: The number of detected peaks in the mass spectra in the test sets before and 
after denoising. The ATMR was compared with VisuShrink. The WBC algorithm was 
used with the ATMR for baseline correction. The SPDBC algorithm was employed to 
eliminate the baseline after denoising using VisuShrink.  
 
TS 1-1 
(mean ± std) 
TS 1-2 
(mean ± std) 
TS 2 
(mean ± std) 
Raw mass spectra 787±39 781±26 778±31 
VisuShrink with 
SPDBC 287±30 289±22 284±25 
ATMR with WBC 124±30 81±7 111±20 
 
4.4.2 Results of baseline correction and denoising 
The results of the ATMR and the VisuShrink algorithms were demonstrated in 
Figure 4.10. The image in the first row is an example raw mass spectrum of TS 1-2, and 
those in the second and third rows are the mass spectra denoised by ATMR and 
VisuShrink, respectively. As can be seen in Figure 4.10, the mass spectrum denoised by 
VisuShrink has artifacts due to the residuals from the denoising process (B2). By 
comparison, the mass spectrum denoised by ATMR shows a smoother curve than 
VisuShrink and has fewer artifacts in the peaks (C2). In particular, VisuShrink could not 
completely remove the chemical noise in the low mass region while my adaptive method 
successfully eliminated it (compare B2 and C2). However, both methods showed 
comparable denoising results in the high mass region. Similarly, it was observed that 
ATMR also outperformed VisuShrink in TS 1-1 and TS 2. Denoising by the VisuShrink 
method left large residuals in the low mass region as compared to ATMR, resulting in 
artifacts in the reconstructed mass spectra. 
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In addition, since the universal threshold tends to be overestimated relative to the 
true noise level in the high mass region, low peaks in the high mass region can be 
unnecessarily removed from the mass spectrum. However, use of the ATMR prevents 
this problem by adaptively estimating the threshold. The baseline line of each mass 
spectrum was also successfully eliminated by WBC in the 8 level approximation 
8
c . The 
SPDBC algorithm also showed comparable performance. No noticeable differences were 
identified between the mass spectra corrected by the SPDBC algorithm and my non-
linear regression based method.  
The efficacy of the ATMR algorithm was tested by investigating the quality of 
peaks detected by a peak detection algorithm. The mass spectrum is a mixture of the true 
peaks from the reference proteins and the false peaks from noise. Thus, if a denoising 
algorithm is successful, the number of peaks detected will be reduced in the denoised 
mass spectra compared to in the raw mass spectra because only a few reference proteins 
(i.e., 4-7 proteins) were in the sample. Peak detection was done on the individual mass 
spectra of each data set and the number of detected peaks was counted. Table 4.2 shows 
the mean numbers of detected peaks from the mass spectra of each data set using 
VisuShrink and ATMR. The mean number of detected peaks from raw mass spectra of 
each data set is also given for comparison. As can be seen in Table 4.2, about 780 peaks 
were consistently detected from the mass spectra across the data sets. VisuShrink reduced 
the number of detected peaks to about 300; however, ATMR made it possible to detect 
far fewer peaks (about 80-120) than VisuShrink. This observation implies that ATMR 
effectively reduced the false positives in peak detection. In addition, the S/N can be used 
as a measure of the quality of detected peaks. The S/N is defined as the ratio between a 
peak height and the median absolute deviation of the mass spectrum near the peak, which 
is considered to be the noise level around the peak [103]. S/N was also dramatically 
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increased due to use of the ATMR algorithm. For example, the original S/N of the 
ovalbumin in TS 1-2 is only 8 without denoising; however, it increased to 10,000 when 
VisuShrink was used, and it is ever more improved to 30,000 by ATMR. 
In summary, ATMR reduced chemical noise in mass spectrometry, which is 
dominant in the low mass region, while VisuShrink was only able to remove noise in the 
high mass region. The superiority of the ATMR algorithm over VisuShrink was 
confirmed by qualitative and quantitative evaluation of the denoising results. It was 
shown that the mass spectra denoised using my algorithm contained far fewer false 
positives than the raw mass spectra or the mass spectra denoised using VisuShrink. In 
addition, the S/Ns of the detected peaks were drastically improved by a factor of 4,000 
when compared to VisuShrink.  
 
4.5 DISCUSSIONS AND CONCLUSION 
In MALDI TOF MS, noise hampers both humans and pattern recognition 
algorithms in observing the true biochemical nature of the sample. As an extension of the 
study of noise from instrumentation in Chapter 3, chemical noise was extensively 
analyzed using the WT in this chapter. The SWT was selected for the study because this 
variant of the WT can make the wavelet coefficients of a given signal shift-invariant, 
allowing for consistent denoising performance for similar signals shifted in time. This 
feature is important for denoising mass spectra in the sense that mass spectra could often 
be phase-shifted because of the innate mass error of the instrumentation. Moreover, the 
SWT enables interval dependent thresholding because the use of DWT decreases the time 
resolution of details and approximations by a factor of 2 as wavelet decomposition 
proceeds. This can be avoided by using the SWT.  
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Unlike noise from instrumentation, chemical noise originates from molecules with 
low molecular weights such as matrix material in MALDI TOF MS; thus, it cannot 
simply be modeled as Gaussian stationary white noise, which is a commonly employed 
assumption in denoising signals based on the WT. It was shown that chemical noise, 
particularly in the low mass region, is neither Gaussian nor white. Moreover, it is not 
stationary either since the noise level decreases over time (mass). Therefore, traditional 
denoising methods based on this assumption (e.g., VisuShrink) are not appropriate to 
remove chemical noise. By contrast, ATMR can reflect the unique nature of chemical 
noise in estimating the optimal threshold based on the observation of multiple realizations 
of chemical noise. One should note that, in order to estimate the threshold for chemical 
noise that reflects the chemical noise characteristics under a certain set of instrumentation 
parameters, the ATMR algorithm needs mass spectra of matrix material plus several 
reference proteins under the same instrumentation parameters as those used for the 
sample parties to be denoised. I also developed a way of eliminating the monotonically 
decreasing baseline in MALDI TOF mass spectra using the WT. To the best of my 
knoweldge, there has been no study that attempted to estimate and remove the 
monotonically decreasing baseline in the wavelet domain. I successfully eliminated the 
baseline using non-linear regression with respect to local minima of the highest level 
approximation of wavelet decomposition.  
The experimental results show that ATMR and WBC are superior to conventional 
denoising and baseline correction algorithms such as VisuShrink and SPDBC algorithm. 
In particular, the ATMR excellently removed noise in the low mass region while 
VisuShrink still left relatively large residuals. WBC showed comparable results to 
SPDBC by successfully eliminating the baseline of a mass spectrum; however, it would 
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be beneficial to use WBC because the high frequency noise reduction and baseline 
correction can be done together in the wavelet domain.  
Non-linear regression based on a two term exponential function for eliminating 
the influence of the reference proteins and smoothing the threshold and baseline was very 
effective. However, the thresholds for the higher level (e.g., 5-6) details tend to be 
overestimated in the low mass region, which might result in the loss of protein 
information. This phenomenon may be due to the fact that the signal amplitude of the 
reference proteins grows quickly in the higher level; the robust regression algorithm 
could not fully correct for this effect. This issue could particularly be resolved by using a 
different regression function instead of the two term exponential function. The two term 
exponential function is suitable for modeling the rapid decrease in the beginning or end 
of a signal. However, several huge outliers in the low mass region (i.e., large amplitude 
of the reference proteins with low mass) can make the function estimate higher than it is 
supposed to be.  
I also faced a similar issue in regard to the WBC algorithm. It was sometimes 
observed that the baseline obtained by WBC was overestimated in the middle mass 
region because of the high peaks of the reference proteins. As a result, small peaks in the 
middle mass region were eliminated by baseline correction. In particular, it is expected 
that the baseline is prone to be overestimated in the case that many high peaks are packed 
in a narrow region. This problem may be alleviated by sparsely sampling the points from 
that region and densely sampling from other regions to reduce the effect of the high 
peaks. However, automatically determining sampling intervals according to the peak 
height would be a technical challenge.  
As mentioned in the previous section, the wavelet analysis also gave some clues 
to how to analyze noise from random ion motions. As can be seen in Figure 4.4 and 4.7, 
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the wavelet coefficients corresponding to the locations of the reference proteins had 
larger amplitudes than others. In particular, the large wavelet coefficients of the 1 level 
detail may originate the multiplicative noise (i.e., noise from random ion motions) in 
mass spectrometry in the sense that the 1 level detail represents the noise frequency band. 
For denoising the multiplicative noise, the characterization of the noise must precede 
threshold estimation because the wavelet coefficients of the reference proteins have large 
amplitudes across all the decomposition levels and it should be investigated which levels 
are related to the multiplicative noise. Then, the noise should be carefully eliminated 
using a locally adaptive threshold, which adjusts the threshold depending on the change 
of the local noise level.  
The conventional wavelet analysis recursively decomposes a given signal into an 
approximation and a detail. That is, the approximation keeps being split into the next-
level approximation and detail until a proper level of decomposition is achieved, while 
the details are not decomposed further. Wavelet packet analysis decomposes the details 
as well as the approximations, providing more perspective on the signal. Thus, wavelet 
packet analysis is expected to more clearly reveal the characteristics of chemical noise or 
multiplicative noise in the wavelet domain than the traditional wavelet analysis.  
In conclusion, the adaptive thresholding using multiple realizations of chemical 
noise and the wavelet baseline correction algorithms effectively removed chemical noise 
from mass spectra. In my study, ATMR and WBC yielded superior results to 
conventional wavelet denoising and baseline correction methods. Several suggestions 
were made for future extensions of my study to identify more realistic thresholds for 
higher level details and a baseline than the current method. In addition, the  
experimental results imply that multiplicative noise can also be removed through wavelet 
analysis, particularly wavelet packet analysis. It is also expected that wavelet packet 
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analysis would enables to precisely remove chemical noise by providing a more clear 
view of the time-frequency composition of chemical noise.
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Chapter 5 GUILT-BY-ASSOCIATION FEATURE SELECTION: 
IDENTIFYING BIOMARKERS FROM PROTEOMIC PROFILES  
5.1 INTRODUCTION 
The goal of proteomic profiling by mass spectrometry is to identify 
proteins/peptides (biomarkers) that are expressed differently between different disease 
states, e.g., control and disease, such that a diagnostic test can be developed. However, as 
discussed in Chapter 2, many bioinformatics challenges must be overcome in order to 
obtain reliable biomarkers for disease detection, prognosis, and treatment monitoring 
[102]. 
One critical issue is the so called curse of dimensionality, which refers to the 
performance degradation of classification due to having few data samples in a high-
dimensional variable space [202]. From a machine learning perspective, the 
protein/peptide species in a protein profile are variables for classification, which are often 
referred to as features. In particular, the height or area of a peak is often taken as a 
feature. The number of samples required for maintaining the same sample density in a 
feature space increases exponentially when another dimension is added. In protein 
profiling using mass spectrometry, selecting effective features that separate diseased 
samples from healthy ones can directly lead to identifying potential biomarkers. This 
operation is referred to as feature selection. The development of feature selection 
algorithms that operate reliably and robustly under this condition is the most critical issue 
in biomarker identification.  
Traditionally, feature selection algorithms are divided into three categories: 
filters, wrappers, or embedded methods [139]. No one feature selection method is 
superior to all the others; every method has its own advantages and disadvantages. For 
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example, filters usually run faster than wrappers, but wrappers are more likely to select 
features that can produce better classification results than filters. Ideally, a feature 
selection algorithm must be able to identify features that are not only discriminant but 
also independent features in order to achieve optimal performance [139, 203]. However, 
many feature selection algorithms, particularly filters, evaluate features solely in terms of 
individual discriminability. Although wrappers consider the interrelationships between 
features, in order for the process to be computationally tractable, a search algorithm such 
as forward selection or backward elimination must be used. The search algorithm 
iteratively forms the best subset of features that maximizes the performance of the 
embedded classifier. However, the search result could be biased because of the heuristic 
and greedy aspects of the search algorithm used in feature selection. For example, 
forward selection or backward elimination determines which feature is supposed to be 
selected or eliminated at the next stage based on the current set of features. Thus, it is 
difficult to guarantee the mutual independency of the selected features. Genetic 
algorithms attempts to avoid such bias by optimizing the selection of subset on the basis 
of natural selection and randomization [204, 205]; however, in general, the running time 
of a genetic algorithm is extremely long compared to other search algorithms.  
In general, highly correlated features do not improve classification performance 
[139]. In a simulation study, Guyon and Elisseeff observed that adding a highly 
correlated feature did not contribute to the information gain for classification unless the 
direction of correlation was orthogonal to that of class separation [139]. In recognition of 
this problem, several machine learning studies have presented feature selection 
algorithms for identifying discriminant and independent features based on information 
theory.  
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Koller and Sahami defined discriminant and independent features as relevant 
features and attempted to obtain relevant features by eliminating features mutually 
independent of class labels (irrelevant features) and features interrelated with other 
features (redundant features) [203]. The principle of this algorithm is that irrelevant and 
redundant features are classified on the basis of expected mutual information with the 
class labels and Markov blanket estimates respectively, and then they are eliminated by 
backward elimination. Hall also developed a similar feature selection algorithm that 
evaluates the relevancy of features on the basis of a combined correlation measure, and 
searches for an optimal subset of features using a conventional search algorithm such as 
forward selection or backward elimination [206]. However, these feature selection 
algorithms involve a search process and repetitive measurement of feature relevancy, 
resulting in a significantly high computational burden. Moreover, relevancy measures 
based on information theory may not be suitable for features from proteomic profiling 
since these measures are based on the estimation of the joint probability density function 
(PDF), which for proteomic data is high dimensional and may be poorly defined given 
the typically moderate number of samples.  
On the other hand, several other studies have attempted to choose relevant 
features by clustering redundant features. Mitra and Pal proposed a feature selection 
algorithm that clusters features together based on the k nearest neighbor principle, and 
picks the feature with the smallest distance from other features within the cluster as a 
representative [207]. Since this algorithm does not require a search process, its running 
time is expected to be shorter than those algorithms introduced above. In addition, the 
pairwise distance definition based on a correlation measure (correlation coefficient or 
covariance) between features is more robust than the independency measure based on 
joint PDF estimation in the analysis of proteomic profiling. However, in this algorithm, 
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the user must specify several parameter values (e.g., the number of neighbors, k) for 
optimal operation. Moreover, merely choosing the least correlated features may decrease 
classification performance since discriminability is not taken into consideration.  
In another study, an attempt was made to group correlated features using 
hierarchical clustering [208]. King used the correlation coefficients between features as a 
similarity measure, and clustered features based on their correlation coefficients in a step-
wise manner. However, specific stopping criteria are not suggested; the algorithm simply 
continues the merging process until only two clusters remains. Obviously, this algorithm 
is not appropriate for analyzing complex data like protein profiles because even 
uncorrelated features can be forced to fall in the same cluster.  
In this chapter, I present a method, referred to as guilt-by-association (GBA), 
which reveals the dependency structure of features in a dataset using a correlation 
measure and a clustering algorithm. In my present study, I employed the correlation 
coefficient and the agglomerative hierarchical clustering algorithm; however, other 
dependency measures or clustering algorithms could be used. It should be also noted that, 
unlike prior studies reviewed above, GBA operates in cooperation with a filter feature 
selection method, such as the two sample t test, in order to select features that are 
discriminant as well as independent. In a previous study, I tested the GBA on simulated 
proteomic data sets, and observed that the GBA successfully distinguished the relevant 
features from other redundant and irrelevant features [109]. In this chapter, I evaluated 
the efficacy of the GBA algorithm with a real SELDI TOF breast cancer data set that had 
been analyzed by Pusztai et al. [111] 
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5.2 MATERIALS AND METHODS  
5.2.1 GBA Algorithm 
MATLAB® 7 (The MathWorks, Inc., Natick, MA) was used throughout the 
study. Selecting an appropriate distance measure is an important issue for cluster analysis 
[207, 209]. In this study, I define the pairwise distance between two features, x1 and x2, as 



















1( )var x2( )
                        (5.2) 
 
where cov and var represent the covariance of two features and variance of a feature 
respectively. This distance measure is not a metric because it cannot satisfy the triangular 
inequality. I took the absolute correlation coefficients in defining the distances since both 
positive and negative correlations indicate dependency between the variables. After 
obtaining the pairwise distances between the features, the GBA algorithm iteratively 
groups the closest ones using agglomerative hierarchical clustering. Single, complete, and 
average linkage were empirically compared, and the average linkage was selected 
because it showed robust performance in a simple simulation study.  
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Figure 5.1: The R2 measure of the breast SELDI Data (solid line). There are 7,052 
features obtained directly from the baseline-eliminated and normalized spectra. The curve 
smoothly increases from 0 to 1 with the number of clusters. The optimal number of 
clusters is determined at the point where two piecewise linear regression lines (dashed 
lines) meet. These lines approximate the R2 curve with the minimum-squared error. As a 
result, clustering stops at 1,111 clusters (dashed dot line). 
 
As a clustering stopping criterion, R-squared (R2) was employed. R2 is defined as 








2                  (5.3)
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R2 has values from 0 (a single cluster of all the elements) to 1 (individual elements as 
clusters), and it monotonically increases in a concave form (Figure 5.1). Because R2 
measures the homogeneity of the clusters at every merging step, a sharp decrease in R2 
indicates that the merging process should be stopped. Figure 5.1 shows an example of R2 
(solid line) as a function of the number of clusters for the breast SELDI data set used in 
this study. As can be seen in Figure 5.1, the R2 is relatively flat until the number of 
clusters reaches about 1,100 (vertical dashed dot line), and then decreases quickly. This 
implies that the smallest number of clusters that keeps the clusters homogenous is about 
1,100. I identified this optimal stopping point using piecewise linear regression since 
simple differentiation of the curve with respect to the number of clusters did not clearly 
reveal the stopping point. As can be seen in Figure 5.1, the dashed lines are the two 
piecewise regression lines that give the minimum squared error of regression, and the 
point connecting these two lines was selected as the stopping point of clustering.  
The features within a cluster are more dependent on each other than those that 
belong to different clusters; therefore, selecting representative features of the clusters can 
minimize the risk of choosing redundant features. In the GBA algorithm, representative 
selection is based on discrimination power, as measured using a metric such as the two 
sample t test. Moreover, as discussed in the previous section, GBA is designed as a 
preprocessing step to reduce the number of features based on feature redundancy prior to 
application of a feature selection routine that emphasizes discrimination power. Thus, the 
choice of the metric for selecting the representative feature of a cluster should be matched 
to the metric optimized in the subsequent feature selection routine. Figure 5.2 
summarizes the GBA algorithm for feature selection. 
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Figure 5.2: The GBA algorithm. The GBA consists of two parts: feature clustering and 
selecting representative features. The GBA calculates the pairwise distance between each 





2( ) , where ( )21, xx!  is the correlation 
estimate of x1 and x2. The agglomerative hierarchical clustering clusters features until the 
stopping criterion is satisfied. A standard filter method (e.g., two sample t test or 
individual ROC analysis) serves selecting representative features from the formed 
clusters. 
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Table 5.1: The four data sets provided by Department of Biostatistics and Applied 
Mathematic at The University of Texas M. D. Anderson Cancer Center. In this study, 
‘March 03 Low Mass Scans’ was used to test the efficacy of GBA.  
Samples/Spectra 
Pre-chemotherapy Post-chemotherapy Data Sets 
Cancer Normal Cancer Normal 
March 03 Low Mass 25/47 15/29 26/49 15/28 
March 03 High Mass 26/47 15/29 26/49 15/28 
June 03 Low Mass 42/84 0/0 30/60 0/0 
June 03 High Mass 42/84 0/0 30/60 0/0 
 
5.2.2 Data set 
SELDI TOF spectra of plasma from women with and without breast cancer were 
used to test the efficacy of GBA. This data set is described by Pusztai [111] and 
additional information is available on the website of the Department of Biostatistics and 
Applied Mathematics at The University of Texas M. D. Anderson Cancer Center 
(http://bioinformatics.mdanderson.org/pubdata.html). The mass spectra themselves can 
also be downloaded from the same location. I briefly summarize the pertinent aspects of 
the data. An IMAC-Cu metal binding chip was used to produce the mass spectra. There 
are a total of four data sets on the website, which were measured at two different time 
points (March 03 and June 03) and optimized to two different mass scanning regions (low 
and high mass regions) (Table 5.1). For my study, I selected ‘March03 Low Mass Scans’, 
which consists of mass spectra of plasma from 15 normal controls and 26 breast cancer 
patients over a low mass range (10-96,900 Da). For quality assurance, all of the samples 
were run in duplicate. This study used the normal mass spectra and pre-chemotherapy 
mass spectra for the cancer patients. Three mass spectra of the healthy controls and five 
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mass spectra of the cancer patients were excluded from the data set by the producers 
because the spectra showed poor signal quality during instrumentation. In addition, I also 
exclude from my analysis three mass spectra that do not have their pairs marked as high-
quality signal in the ‘March03 High Mass Scan’ set. Also, one cancer sample was 
excluded because it did not have a pre-chemotherapy measurement. Thus, I used 29 mass 
spectra of 15 normal controls and 47 mass spectra of 25 cancer patients in my analysis 
(Table 5.1). Since the biochemical processes of sample preparation and detailed clinical 
information of the samples are not within the scope of this chapter, I refer the reader 
interested in these topics to Pusztai et al. [111] and the information files posted on their 
website. 
 
5.2.3 Data processing 
Data preprocessing consists of three steps: baseline elimination and peak 
detection, normalization, and peak alignment across the spectra. The baseline of each 
mass spectrum was eliminated using the simultaneous peak detection and baseline 
correction (SPDBC) algorithm developed by Coombes et al [103]. This algorithm detects 
the peaks in a given mass spectrum within a moving window, estimates the baseline 
using the peak-free leftover spectra in the window, and subtracts it from the original mass 
spectrum. During peak detection, peaks within mass resolution ( mm ! ) of 200, which is 
set smaller than the typical mass resolution of SELDI TOF (300-400) to raise peak 
detection sensitivity, are combined into a one peak. In the SPDBC algorithm the signal to 
noise ratio (S/N) is defined as the ratio between the height of a peak and the median 
absolute deviation (MAD) from the median in the window around the peak [103]. The 
peaks with S/Ns less than 3 are eliminated from the peak list.  
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After baseline elimination and peak detection, the mass spectra were normalized 
with respect to the total ion current (TIC) of the mass region of 2,000-12,000 Da since the 
low mass region (< 2,000 Da) of SELDI TOF is generally corrupted by chemical noise 
[42, 51], and the high mass region (> 12,000 Da) has very low intensity peaks. Thus, only 
peaks within the middle mass region (2,000-12,000 Da) were considered for further 
analysis.  
Since peaks representing a certain protein do not occur at exactly the same mass 
location across multiple mass spectra, peaks must be grouped together based on the mass 
accuracy of the mass spectra to make inferences about overall patterns across multiple 
spectra. This process is referred to as peak alignment. The mass accuracy of this breast 
SELDI TOF data set does not appear to have been reported. I assumed that the mass 
accuracy was at least 0.1%, a value reported frequently in other studies [211, 212]. The 
peak alignment process yielded 107 peaks.  
Most of the samples have more than one mass spectrum because the samples were 
run in a duplicate manner. Thus, as Pusztai et al. [111] did in their analysis, I generated a 
consensus peak list by averaging each pair of replicate peak lists of the same sample.  
Peak detection and peak alignment reduce the number of features by selecting the 
representative peaks of protein species from raw mass spectra. This process is similar to 
GBA in that the peaks within the resolution or mass accuracy would be highly correlated 
and peak detection and peak alignment removes those redundancies. However, while 
peak detection and peak alignment perform this function only on features of similar 
! 
m z  
values, GBA can provide a global view of the relationships between all the features. 
Thus, in addition to applying GBA after peak detection and peak alignment, I also 
investigated the direct application of GBA to the middle mass region (2,000-12,000 Da) 
of normalized mass spectra, which consists of 7,052 
! 
m z  points (features). 
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5.2.4 Experimental design 
In this study, the two sample t test was used as a simple filter method for feature 
selection. As in Pusztai et al.’s analysis, a constant (0.5) was added to the denominator of 
the t statistic so that large t values are not be generated simply because the variances of 
the two groups (cancer and normal) are small due to very low intensities near zero, rather 




x " y 
var(x ) + var(y ) + k




x  and 
! 
y  are the mean estimates of two groups and 
! 
var(x ) and 
! 
var(y ) are the 
variance estimates of 
! 
x  and 
! 
y . k is a constant, 0.5 in this study, and this value was also 
used by Pusztai et al. [111]. I did not try to optimize this constant for my normalized 
mass spectra. 
Two feature selection methods, t test alone and t test combined with GBA, were 
compared with different numbers of features selected. In the case of t test alone, features 
were simply selected according to their discrimination abilities; features with large 
absolute t values were chosen. However, in the case of GBA combined with t test, a 
feature with a large absolute t value was not selected if it was grouped with another 
feature with larger absolute t value. I evaluated the selected features in terms of the area 
under the Receiver Operating Characteristic curve (AUC) of a logistic regression 
classifier trained with those features.  
The AUC of a classifier was obtained via 10-fold cross-validation to alleviate the 
difficulty of accurate evaluation due to the small data set size (40 samples). The entire 
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data set was randomly split into 10 non-overlapping partitions. Features were selected 
and a classifier was trained on nine partitions, and the classifier output values of the 
samples belonging to the remaining partition were obtained using the trained classifier. 
This process was repeated such that every partition was withheld once, and then a single 
AUC was estimated based on the classifier output values from the 10-fold cross-
validation.  
 The whole process was repeated with different numbers of features selected (1-
20) to see the performance change of GBA over the number of features. The range was 
set based on the numbers of potential biomarkers reported in similar studies [37, 40, 58, 
80, 83, 86, 137]. As mentioned in the data preprocessing section, the same experiments 
were done both with peaks identified by preprocessing (107 features) and directly on the 




Figure 5.3: The summary of the experimental design. I tested the efficacy of the GBA 
with the peaks detected by the SPDBC peak detection algorithm [103], and the mass 
spectra without peak detection. Features were selected by t test alone and t test with GBA 
respectively and the selected features were evaluated in terms of the AUC of a logistic 
regression classifier trained with those features. The AUC of a classifier was obtained via 
10-fold cross-validation to alleviate the difficulty of accurate evaluation due to the small 
data set size (40 samples).
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Figure 5.4: The AUCs of the logistic classifiers trained on the features selected by two 
sample t test alone and those by t test with GBA with the peaks identified by 
preprocessing. The error bars represent the standard deviations obtained from three 
different 10-fold cross-validation runs. The comparison of t test alone and t test with 
GBA was repeated with the number of selected features varying from 1 to 20 (horizontal 
axis). t test with GBA shows better than or comparable to t test alone. The curve of GBA 
more quickly arrives at a higher value than t test alone.
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5.3 EXPERIMENTAL RESULTS 
5.3.1 Two sample t test vs. t test with GBA on the peaks identified by preprocessing 
The discrimination abilities of the individual features were measured using Eq. 
5.4. In the case of t test alone, the features were sorted by their absolute t values, and the 
top N features were used for building a classifier. Since this feature selection process was 
performed inside of the cross-validation loop, the t values of the features were separately 
estimated for every run of the cross-validation. Similarly, in the case of t test with GBA, 
the representative features of the feature clusters identified by GBA were evaluated and 
representatives with the N largest t values were selected for classification.  
Figure 5.4 shows the AUCs of t test alone and of t test with GBA over various 
numbers of features obtained from the peaks identified by preprocessing. The x axis 
represents the number of selected features, and the y axis represents the average AUCs 
(solid and dashed lines) and the standard deviations (error bars) obtained from three 
different cross-validations. It was observed that t test alone and t test with GBA produced 
equivalent performance (0.60-0.78) until about three features were selected, and then t 
test with GBA began to outperform t test alone. Considering the standard deviations, the 
difference between these two AUC curves of t test alone and t test with GBA is moderate 
when a small number of features are used, but t test with GBA is clearly superior as more 
features are included. On average, the AUCs of GBA reached the maximum (≈ 0.79) 
when four features were included, and then remained above 0.72 whereas the AUCs of t 
test alone decreased to about 0.67 when the 6th-9th features were included, and then 
sharply fell again to about 0.6 when the 13th-16th features were added. This observation 
implies that the 6th-9th and 13th-16th features selected by t test alone are highly correlated 
with those previously selected, resulting in the reduction of classification performance. In 
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contrast, the AUC of t  test with GBA is stable, remaining over 0.72, which suggests 
that the correlations among the features selected by t test with GBA were kept low by 
GBA.  
In order to confirm my observation, I investigated how the features selected by t 
test alone were associated with each other and how well GBA identified the association 
structure of the features. Table 5.2 lists the top 20 features as ranked by t test alone over 
10-fold cross-validation. The first column of Table 5.2 represents the mass to charge 
ratios ( zm ) of the selected features, and the second column shows their mean t values 
estimated from the 10-fold cross-validation. Each pair of numbers from the 3rd column of 
Table 5.2 indicates which position a feature was ranked at by t test alone (outside of the 
parentheses), and how many times the feature was ranked at the position (inside of the 
parentheses) during the 10-fold cross-validation. For example, zm  7766.9 in the first 
row of Table 5.2 has a mean t value of -0.00313 and was ranked #1 by t test alone six 
times (i.e., 1(6)) and #2 four times (i.e., 2(4)) during the 10-fold cross-validation. The t 
values in the last column of Table 5.3 are fairly low (< 0.003) compared to the t values 
reported by Pusztai et al. (< 4) [111] This may be because a large value (0.5) was 
selected for k of Eq. 5.4 as compared to the variances of peaks. I normalized the mass 
spectra with respect to the TIC of the mass region of 1,200-12,000 Da while Pusztai et al. 
selected a different mass region for normalization [111]. Therefore, the variances of 
peaks may have changed after normalization, resulting in low t values. However, the 
order of the features is not be affected by the choice of k. 
Table 5.3 shows how these features were clustered by GBA. The features in each 
row of Table 5.3 belong to the same cluster, and the feature with an asterisk has the 
highest t value among those in the cluster (representative feature). The pairwise distances 
among the features belonging to a cluster are within from 0.02 to 0.23 (correlation of 
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0.98-0.77) while those among features in different clusters range from 0.25 to 0.93 
(correlation of 0.75-0.07). As can be seen in Table 5.2, zm  7766.9, 4443.8, and 2026.0 
were ranked 1st-3rd, and these features were not significantly correlated together (Table 
5.3). They belong to three different clusters (Clusters 1-3). GBA does not improve feature 
selection in the case that the top N features are independent and the N (or less than N) 
features already show the best classification.  
However, when they can be grouped into a smaller number of clusters than N 
(i.e., in the cases that some or all of the N features were significantly correlated), the 
combination of t test and GBA makes it possible to select more powerful feature sets than 
t test alone. In Figure 5.4, t test with GBA began to produce higher AUCs than t test 
alone when more than four features were selected; although the improvement is not large 
at first. zm  4289.5 and 8939.6 were ranked by t test at the 4th or 5th positions (mean t 
value of 0.00145 and 0.00116 respectively in Table 5.2). While zm  4289.5 was not 
redundant to the top three features ( zm  7766.9, 4443.8, and 2026.0), zm  8939.6 was 
highly correlated with zm  4443.8 (Cluster 2 in Table 5.3). Thus, including zm  
8939.6 decreased the AUC. In contrast, when GBA was used with t test, zm  8939.6 
was excluded by GBA and only zm  4289.5 was selected as the 4th feature, resulting in 
higher AUCs than t test alone.  
Similar observations were also made for the features ranked by t test as 6th-9th and 
13th-16th. For example, zm  3890.6 and 7936.4 were mainly ranked at the 7th and 12th-
14th positions respectively, but these features were found to be highly associated with 
zm  7766.9, which is the top ranked feature (Table 5.2). zm  7936, which was mainly 
ranked at the 13th or 15th positions, was also significantly correlated with zm  3164.1, 
which was ranked 6th. 
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Table 5.2: The features selected by t test alone from the peaks identified by preprocessing 
during the 10-fold cross-validation. The first column represents the mass to charge ratios 
( zm ) of the features, and the second column contains their mean t values calculated 
from the 10-fold cross-validation. The ranks and numbers of occurrences of the features 
are shown next. For example, 
! 
m z  7766.9 in the first row has a mean t value of -
0.00313 and was ranked #1 by t test alone six times (i.e., 1(6)) and #2 four times (i.e., 
2(4)) during the 10-fold cross-validation. The features are sorted by their absolute mean t 
values. 
! 
m z  (Da) Mean t value* Rank (Frequency) 
7766.9 -0.00313 1(6) 2(4)    
4443.8 0.00265 1(2) 2(6) 3(2)   
2026.0 0.00201 1(2) 3(4) 4(2) 5(1)  
4289.5 0.00145 3(4) 4(5) 5(1)   
8939.6 0.00116 4(3) 5(7)    
3164.1 0.00084 5(1) 6(6) 7(1) 8(2)  
3890.6 -0.00077 6(1) 7(5) 8(2) 9(2)  
2232.6 0.00075 6(3) 7(3) 8(2) 9(1) 10(1) 
4146.3 0.00067 7(1) 8(3) 9(5) 10(1)  
5911.2 0.00057 8(1) 9(2) 10(5) 11(1) 13(1) 
3435.3 0.00051 10(3) 11(7)    
6986.8 0.00042 11(1) 12(6) 14(3)   
7936.4 -0.00038 12(3) 13(2) 14(4) 16(1)  
2745.0 0.00032 12(1) 13(4) 15(1) 16(2)  
2088.4 0.00030 13(2) 14(1) 15(4) 16(1)  
2795.2 0.00026 14(1) 15(2) 16(1) 19(1) 20(2) 
7846.5 -0.00026 15(1) 16(2) 17(3) 18(1) 19(1) 
6856.8 0.00025 15(1) 16(3) 17(1) 18(1) 20(2) 
2304.3 -0.00024 15(1) 17(2) 18(3) 19(1)  
4747.8 0.00023 17(1) 18(1) 19(2) 20(3)  
8607.1 -0.00021 17(2) 18(2) 19(2) 20(1)  




Table 5.3: The clusters of the features ranked as top 20 by t test during the 10-fold cross-





1 3890.6 7766.9* 7846.5 7936.4 
2 4443.8* 4747.8 6986.8 8939.6 
3 2026.0*    
4 4289.5* 6856.8   
5 3164.1* 3435.3 4146.3  
6 2088.4 2232.6*   
7 5911.2*    
8 2745.0*    
9 2304.3*    
10 2795.2*    
11 8607.1*    
* The feature with the highest discrimination ability in the cluster.  
 
Another interesting finding about GBA is that it can work as a deconvolution 
algorithm for multiply charged proteins. Although, in general, molecules are singly 
charged by the MALDI (SELDI) ionizing process, sometimes molecules are multiply 
charged. If a molecule is multiply charged, its corresponding peak in a mass spectrum 
occurs approximately at the ratio of its molecular weight and charge amount. In general, 
it is impossible to know whether two peaks with multiple zm  values originate from the 
same molecule or not without prior information on the analyte. However, they are highly 
likely to represent the same protein if two peaks with multiply related zm  values have 
a strong correlation, which can be revealed by GBA. In Cluster 1 of Table 5.3, zm  
7766.9 is approximately twice zm  3890.6 and these two features are highly correlated 
(correlation of 0.97). Similarly, zm  8939.6 and zm  4443.8 are also strongly 
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correlated (correlation of 0.85). Based on these observations, it is highly probable that 
zm  7766.9 and zm  3890.6 actually represent one protein, and likewise zm  8939.6 
and 4443.8 represent a single protein.   
In summary, there are strong correlations between the features selected solely by t 
test, and these correlations are the major reason for performance degradation when 
features are selected. In contrast, when t test is used with GBA, the classification 
performance does not decrease as more features are selected; it remains steady since 
GBA avoids selecting features correlated strongly with other discriminant features. This 
observation is validated by the fact that the average distance of the features selected by t 
test with GBA was kept as high as 0.77 (correlation of 0.23) while some of the features 
selected by t test alone have high correlations with each other. The largest AUC of GBA 
was obtained when 16 features were used (≈ 0.80). However, I favor the simplest model 
for a given level of performance. This is often referred to as Occam’s razor in machine 
learning. Thus, the top four features can be taken as potential biomarkers. In obtaining 
these four features as biomarker candidates, GBA eliminated a redundant feature from 




Figure 5.5: The AUCs of the logistic classifiers trained on the features selected by two 
sample t test alone and those by t test with GBA with the normalized mass spectra. The 
error bars represent the standard deviations obtained from three different 10-fold cross-
validation runs. The comparison of t test alone and t test with GBA was repeated with the 
number of selected features varying from 1 to 20 (horizontal axis). t test with GBA is 
better than or comparable to t test alone. In particular, it is interesting that GBA can be 
used as an alternative to peak detection when applied to the normalized data since it 
successfully detected groups of features that represent specific proteins. 
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5.3.2 Two sample t test vs. t test with GBA on normalized mass spectra 
The benefits of GBA were clearly apparent when it was applied to the normalized 
mass spectra without peak detection. As in the analysis of the peaks identified by 
preprocessing, I also performed three different 10-fold cross-validations to obtain the 
standard deviations of the AUCs. As can be seen in Figure 5.5, the AUCs were typically 
higher for t test with GBA than for t test alone except for when 10-13 features were used. 
The average AUC of GBA reached 0.84 when five features were used while the AUC of t 
test alone remained at 0.57. After the AUC of t test with GBA reached the maximum 
value, it continually decreased. The AUC of t test alone arrived at its maximum (≈ 0.70) 
until 10 features were selected and then gradually decreased below the AUC of t test with 
GBA. This observation means that the first 5-6 features selected by t test alone were 
highly correlated, but the features selected next are less correlated with the previous ones, 
resulting in the increasing AUC of t test alone until 10 features were included.   
Table 5.4 shows the ranks of the top 20 features by t test alone. As can be seen in 
this table, it was observed that the features can be grouped by their zm  values. For 
example, the first eight features have zm  values in the range of from 2022.7 to 2028.4. 
Because the normalized mass spectra were directly used without peak detection, a protein 
is represented by several features with similar zm  values due to the finite resolution of 
the mass spectrometer and the isotopes of the protein. In general, peak detection 
algorithms are used in order to extract representative features that summarize the 
information of the proteins in the sample based on certain criteria such as signal to noise 
ratio. Moreover, since features with similar zm  values tend to be strongly correlated, 
peak detection algorithms actually select the representative features from the groups of 
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features with high correlations and similar zm  values. This implies that GBA can be 
used as an alternative to peak detection.   
Table 5.5 shows the feature clusters containing the features that were ranked by t 
test alone as 1st-20th. As can be seen in Table 5.5, these features were clustered into four 
groups and the features in each group have similar zm  values, which implies that only 
four features among those selected by t test alone are independent, and this redundancy of 
the features lowered the AUC. It was observed that the distances within the clusters are 
very low (0-0.09) while the distances between the clusters range from 0.41 to 0.90. This 
observation shows that GBA can correctly detect the groups of features representing the 
same proteins and select features with high discrimination abilities when it is applied to 
raw mass spectra. Interestingly, these feature clusters correspond to those obtained in the 
peaks identified by preprocessing. Cluster 1 includes the features from zm  7765.3 to 
zm  7778.3, which correspond to zm  7766.9 of Cluster 1 in Table 5.3. Similarly, 
Clusters 2, 3, and 4 are directly associated with the representative features of Clusters 2, 
3, and 4 ( zm  4443.8, 2026.0, and 4289.5, respectively) in Table 5.3. This result also 
supports that GBA does peak detection implicitly and assists in identifying discriminant 
ones from the detected features.  
The use of GBA for normalized mass spectra made it possible to select features 
that are independent as well as discriminant. The effect of GBA was clearer for the case 
in which raw mass spectra were directly used than for the case in which peaks were 
identified by the preprocessing because GBA successfully grouped the groups of features 
that may represent the same proteins based on only correlations among the features, and 
selected the most discriminant representative features from the groups. This experimental 
result also indicates that GBA performs peak detection without heuristic parameter 
determination as required by other peak detection algorithms.
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Table 5.4: The features selected by two sample t test alone from the normalized mass 
spectra during the 10-fold cross-validation. The first column represents the mass to 
charge ratios ( zm ) of the features, and the second column contains their mean t values 
calculated from the 10-fold cross-validation. The ranks and numbers of occurrences of 
the features are shown next. The features are also sorted by their absolute mean t values. 
! 




t  value* Rank (Frequency) 
7771.8 -0.00302 1(6) 2(1) 4(1) 7(1) 9(1)  
7770.1 -0.00294 2(4) 3(2) 4(1) 7(1) 8(1) 13(1) 
7773.4 -0.00294 2(2) 3(4) 6(2) 8(1) 9(1)  
7775.0 -0.00273 4(2) 5(3) 7(1) 9(1) 10(1) 11(1) 
7768.5 -0.00271 4(3) 5(1) 7(1) 8(1) 9(1) 10(2) 
4443.8 0.00264 1(2) 4(1) 5(1) 6(2) 7(1) 14(1) 
4442.6 0.00262 2(1) 3(1) 5(1) 6(1) 7(1) 8(1) 
4445.0 0.00249 3(1) 6(1) 8(2) 9(1) 10(1) 12(2) 
7776.6 -0.00243 6(1) 8(1) 9(2) 10(2) 13(1) 14(1) 
4441.3 0.00237 4(1) 9(2) 11(3) 15(1) 19(1) 20(1) 
7766.9 -0.00236 6(1) 10(2) 11(2) 12(1) 14(1) 15(1) 
4446.2 0.00220 5(1) 11(1) 12(2) 13(1) 16(1) 17(1) 
7778.3 -0.00208 12(1) 13(2) 14(2) 18(1) 19(2)  
2025.1 0.00205 1(2) 5(1) 7(1) 8(1) 14(1)  
4440.1 0.00200 6(1) 13(2) 15(2) 18(1)   
2026.0 0.00198 3(1) 4(1) 7(1) 8(1) 9(1) 16(1) 
7765.3 -0.00194 15(1) 16(1) 18(1)    
2024.3 0.00194 2(2) 7(1) 11(1) 14(1) 20(1)  
2026.8 0.00187 5(1) 8(1) 10(1) 13(2) 19(1)  
2023.5 0.00185 5(1) 12(1) 17(1) 18(1)   
4447.5 0.00183 7(1) 15(1) 16(2)    
7779.9 -0.00173 17(3) 18(1)     
2027.6 0.00166 12(3) 16(1) 19(1)    
2022.7 0.00161 6(1) 11(1) 17(1)    
4438.9 0.00159 11(1) 17(1) 18(1)    
4448.7 0.00147 12(1) 19(1)     
2028.4 0.00145 18(1) 19(1) 20(1)    
4285.9 0.00144 16(1) 18(1) 19(1) 20(1)   
4287.1 0.00143 15(1) 19(1) 20(1)    




Table 5.5: The clusters of the features ranked as top 20 by t test from the normalized 
mass spectra during the 10-fold cross-validation. The clustering results were very 
consistent throughout the cross-validation. All of the features ranked within 20 were 
grouped into 4 clusters. The clusters are also sorted by their representative features’ 
absolute mean t values. 
Cluster 
! 
m z  (Da) 
1 7765.3 7766.9 7768.5 7770.1 7771.8* 7773.4 7775 7776.6 7778.3 
2 4438.9 4440.1 4441.3 4442.6 4443.8* 4445.0 4446.2 4447.5 4448.7 
3 4285.9* 4287.1        
4 2022.7 2023.5 2024.3 2025.1* 2026.0 2026.8 2027.6 2028.4  
* The feature with the highest discrimination ability in the cluster. 
 
Table 5.6: The features frequently ranked from 1 to 5 by t test with GBA from the peaks 
identified by preprocessing and the normalized spectra are compared with those reported 
in Pusztai et al.’s study. It is observed that the features selected from the peaks identified 
by preprocessing and those from the normalized spectra have very similar mass to charge 
ratios. This implies that GBA can be used as an alternative to peak detection. Two 
features were commonly identified by t test with GBA and Pusztai et al.’s method (
! 
m z  
4444 and 3165). According to Table 5.3, the 
! 
m z  4444 is highly correlated with 
! 
m z  
8940 (≈ 0.85) and the 
! 
m z  is almost half of 8940. It is highly probable that 
! 
m z  4444 
and 
! 
m z  8940 represent multiply charged states of the biologically same protein. 
t  test with GBA 
Peaks identified by 
preprocessing  
(Da) 
Normalized spectra  
(Da) 
Pusztai et al. Cancer 
2004  
(Da) 
2026.0 2025.1  
3164.1 3162.0 3165 
  3440 
  4115 
4289.5 4285.9  
4443.8 4443.8 4444 
7766.9 7771.8  
  8940 
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5.3.3 Comparison with Pusztai et al.’s finding 
The features selected by t test with GBA from the peaks identified by 
preprocessing and those from the normalized mass spectra were compared with the 
features reported by Pusztai et al [111]. The features in the first two columns of Table 5.6 
are the top five features selected by t test with GBA from the peaks identified by 
preprocessing and the normalized mass spectra respectively, and the features in the last 
column are the five features identified by Pusztai et al. As can be seen in Table 5.6, the 
zm  values of the features selected from the peaks identified by preprocessing agreed 
with those selected from the normalized mass spectra. This indicates that GBA is able to 
extract non-redundant features that represent the proteins in the analyte, so it can be used 
as an alternative to peak detection.  
Two of the features selected by t test with GBA ( zm  4444 and zm  3165) are 
in the feature list reported by Pusztai et al. They had also used the same t test; however, 
Pusztai et al. normalized the mass spectra with respect to the total ion current after the 
1000th time tick [111]; thus, their list of features is not exactly the same as ours. 
Moreover, my GBA analysis implies that the feature zm  4444 corresponds to doubly 
charged molecules of zm  8940 because they are highly correlated (correlation of 0.85). 
 
5.4 DISCUSSIONS AND CONCLUSION 
To achieve accurate classification performance, features must be both 
discriminant and independent. In general, feature selection methods, especially filter 
methods, do not take into account the relationships between features, which can lead to 
the degradation of overall discrimination ability. On the other hand, wrapper-based 
feature selection methods search for a best set of features by optimizing the group 
discrimination ability. However, the involvement of a search algorithm in feature 
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selection can increase the computational load (e.g., genetic algorithms) or result in bias 
during searching (e.g., forward selection or backward elimination). Therefore, feature 
selection based on a wrapper method can take a long time and may converge to solution 
that is only locally optimal. In comparison with these conventional feature selection 
methods, GBA successfully eliminates the redundancy among features by clustering 
closely correlated features, which enables the selection of more discriminant and 
independent features in a moderate amount of time.  
When there are strong correlations between discriminant features, using a filter 
method with GBA is more beneficial than using a filter only because GBA eliminates the 
redundancy between discriminant features, maximizing the discrimination ability of the 
selected feature. When there are not strong correlations between discriminant features or 
when there are strong correlations only between non-discriminant features, using a filter 
method with GBA is comparable to using a filter alone and two methods would end up 
with similar features.  
In addition, GBA makes it possible to identify features that represent multiply 
charged molecules of the same protein by elucidating the relationships between features. 
The experimental result of direct GBA application to the normalized mass spectra 
without peak detection demonstrates that GBA can serve as an alternative to peak 
detection and peak alignment because multiple features that originate from the same 
protein molecules have strong correlations and similar zm  values. Most conventional 
peak detection and alignment methods reduce feature redundancy with only a local scope, 
and parameters relating to resolution, mass accuracy, and signal to noise ratio must be set 
heuristically by the user. GBA eliminates feature redundancy based on a global 
correlation measure and it does not require such parameter choices. However, it should 
be noted that the computational running time increases quadratically with the number of 
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features. Thus, the runtime of GBA can be slow when a large number of features are 
analyzed.  
The next step to identifying biomarker candidates would be to prove whether the 
features identified are biologically meaningful. In other words, the proteins 
corresponding to the selected peaks should be identified. Pusztai et al. searched ExPASy 
[213] to identify proteins of approximately the zm  identified in their analysis [111]. I 
also attempted to identify proteins with the similar mass values of my findings. However, 
it is difficult to identify proteins using only their mass information because even the 
simplest search, TagIdent, requires the mass range and isoelectric point (PI) range as 
minimum parameters. Obviously, different combinations of parameter values can lead to 
different search results for a given mass value. In my search, I arbitrarily set the relative 
mass range to 1% and the PI range from 4.5 to 8.5 [214], which is believed to cover most 
of the PI ranges of human proteins. For zm  7766.9, a TagIdent search returned eight 
possible matches (Table 5.7). Some of the matched proteins are related with diseases. For 
example, Small inducible cytokine A3-like 1 and Small inducible cytokine A3 are known 
to work as an inhibitor of HIV-I virus [215]. P8 MTCP-1 is also related with a disease; it 
was reported to be overexpressed in T-cell leukemia. None of these proteins also do have 
any known direct association with breast cancer, but zm  7766.9 seems to reflect the 
immune responses of the body with respect to breast cancer. I performed similar searches 
for the other proteins presented in Table 5.6, but I could not identify proteins that are 
known to be directly related with breast cancer. For more accurate results, protein/peptide 
identification through immunoassay or tandem mass spectrometry would be necessary. 
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Table 5.7: The eight possible proteins that match to 
! 
m z  7766.9 based on the TagIdent 
search results. The relative mass error was set to 1%, which is believed as the typical 
mass error rate of SELDI TOF, and the PI was also arbitrarily set to 4.5-8.5.  
! 
m z  (Da) Possible Proteins 
Small inducible cytokine A14 
Small inducible cytokine A3-like 1  
Small inducible cytokine A3 
Small inducible cytokine A4 
High affinity immunoglobulin epsilon receptor gamma-subunit 





In conclusion, this chapter presents a feature selection algorithm that searches for 
discriminant and independent features through feature clustering. In my study, GBA 
almost always yielded better results than t test alone when GBA was tested on the breast 
cancer SELDI TOF data set. Even though GBA was designed for proteomic profiling, 
GBA can be extended to other types of data that require extensive feature selection. 
Ordinal features can also be handled by GBA if the rank correlation is used to estimate 
the correlations between features. GBA also has the potential to reduce the biochemical/ 
computational burdens by means of suggesting non-redundant candidates of potential 
disease biomarkers from a complex protein samples like SELDI TOF mass spectra. In 
addition, GBA showed potential as a feature reduction technique without peak detection 
by removing peaks from related protein species.  
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Chapter 6: DISCUSSIONS AND CONCLUSION 
6.1 SUMMARY OF WORK 
Proteomic profiling by MALDI TOF MS is a very powerful method for 
identifying potential biomarkers for diagnosis and prognosis of disease. However, since 
MALDI TOF suffers from several types of noise, the subtle but pathologically useful 
information in the mass spectra can be difficult to discern. On the other hand, due to the 
notoriously complex nature of protein profiles by MALDI TOF MS, methods are needed 
for selecting the most informative peaks from the spectra.  
In an effort to reducing noise in MALDI TOF MS, an extensive noise model was 
proposed and each noise component was separated and analyzed according to the model. 
In Chapter 3, I hypothesized that noise in MALDI TOF MS is composed of three major 
components of noise: noise from instrumentation, noise from random ion motion, and 
noise from chemical impurities in the sample (chemical noise). Noise from 
instrumentation was analyzed using parametric power spectral density estimation. In this 
dissertation, I employed the Burg algorithm for multiple segments developed by de 
Waele and Broersen [107] in order to increase the accuracy of the estimation. The 
experimental results revealed that noise from instrumentation is a mixture of several 
types of physical and electrical noise such as thermal noise, 
! 
1 f  noise, and periodic 
interferences from the internal/external circuits of the mass spectrometer. My simulation 
study also showed that noise from instrumentation might not make a strong impact on the 
quality of mass spectra. However, unlike noise from instrumentation, chemical noise 
seriously affects mass spectra by adding a monotonically decreasing baseline and high 
frequency noise, particularly to the low mass region of the spectra. Therefore, in Chapter 
4, I characterized chemical noise and developed a wavelet-based denoising algorithm. 
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Chemical noise in MALDI is mainly caused by matrix material in the sample, which is 
small organic substance such as sinapinic acid. The matrix material helps 
proteins/peptides to be ionized without thermal damage by the laser. However, since the 
matrix molecules are also ionized together with analytes by the laser, they also produce 
undesired interferences with the signal of proteins/peptides in the sample. Chemical noise 
is non-stationary and non-white, characterized by its monotonically decreasing baseline 
and variance over time. I developed a denoising method for estimating adaptive 
thresholds using multiple realizations of chemical noise and a baseline correction 
algorithm for eliminating the baseline in the wavelet domain. The comparison of my 
algorithms with other conventional denoising and baseline correction algorithms showed 
that my algorithms are superior to traditional methods.  
In machine learning, ideal features are discriminant and independent. My novel 
feature selection algorithm, guilt-by-association (GBA) feature selection, can make it 
possible to do this through a correlation-based similarity measure and clustering 
algorithm. GBA groups highly similar features together and selects the representative 
features in conjunction with a regular filter method such as the two sample 
! 
t  test. The 
efficacy of GBA was investigated using a simulation and a real breast cancer SELDI TOF 
data set. The experimental results showed that GBA in combination with the 
! 
t  test 
improved classification performance. Moreover, GBA demonstrated its potential as an 
alternative to conventional peak detection and alignment algorithms by successfully 
identifying local peak groups. It also deconvolved multiply charged states of the same 
proteins.  
In this dissertation, novel methods for denoising and feature selection were 
presented. The methods have been developed to handle complex proteomic profiles by 
MALDI TOF MS for potential biomarker identification, and have shown their 
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tremendous potential for removing artifacts and extracting the key information for 
characterizing the pathological state of a disease from raw data. In the following section, 
several suggestions for future studies will be made from an engineering perspective. 
 
6.2 SUGGESTIONS FOR FUTURE STUDIES 
As described in Chapter 2, biomarker identification utilizing mass spectrometry 
generally consists of five steps: preprocessing, feature extraction, feature selection, 
classification, and evaluation. When this research area began to attract scientific interests, 
many computer scientists or computational biologists put more weight on classification. 
They attempted to find subtle molecular “patterns” from mass spectra by almost blindly 
applying sophisticated machine learning algorithms and reported that their experimental 
results looked promising. However, subsequent studies questioned about the efficacy of 
these initial experiments, pointing out that the “patterns” identified by the machine 
learning algorithms could be simply due to chance differences, between the diseased and 
healthy groups. Since then, preprocessing, feature extraction, and feature selection have 
attracted more attention because these methods can improve the reliability of 
classification. No matter how effective a machine learning algorithm is used, it cannot be 
expected to have statistically reliable results from poorly preprocessed data or coarsely 
extracted and selected features. However, despite of the importance of these research 
areas, the studies regarding preprocessing, feature extraction, and feature selection for 
mass spectrometry are still in their infancy.  
In particular, noise analysis still remains underexplored. In previous studies, ad 
hoc methods such as use of a moving average window have been employed to reduce 
noise without any efforts at first statistically characterizing noise. Therefore, it is 
necessary for researchers with electrical engineering backgrounds, particularly stochastic 
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signal processing, to join this research area for rigorous analysis and reduction of noise in 
mass spectrometry. The use of wavelet analysis or wavelet packet analysis for denoising 
mass spectra is particularly promising (Chapter 4). Research on adjusting and applying 
these powerful signal processing techniques for noise analysis mass spectrometry is in the 
early stages.  
Since biomarker identification using mass spectrometry generally includes 
comparison of multiple mass spectra, normalization must be applied to make the mass 
spectra comparable to each other. The importance of normalization in microarray data 
analysis has been demonstrated by several studies [216, 217]. However, up to the best of 
my knowledge, there have no studies that extensively compare a variety of normalization 
methods in mass spectrometry data analysis. Studies regarding normalization will also 
make significant impacts on the biomarker identification research area.  
Unlike typical machine learning tasks, only a moderately small number of 
samples are available while a huge number of features are produced by mass 
spectrometry (Chapter 2). Thus, the learning algorithm suffers from the curse of 
dimensionality (Chapter 2 and 5). It would be beneficial to develop algorithms that can 
efficiently reduce the dimensionality while keeping statistically important features in the 
reduced feature set.  
Finally, prompt biological evaluation of findings obtained from feature selection 
or classification are needed. For example, when potential biomarkers are proposed, these 
candidates should be promptly validated using protein/peptide identification through 
immunoassay or tandem mass spectrometry. In Chapter 5, I performed a very simple 
peptide/protein search using TagIdent provided by ExPASy, but it did not help to clearly 
identify the candidates. Thus, more sophisticated biochemical validation must follow the 
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types of analysis presented in this dissertation. Increased collaboration between engineers 
and biochemists will be needed to achieve this goal. 
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